1 00:00:06,920 --> 00:00:10,720 >>THANK YOU FOR JOINING US AT 2 00:00:10,720 --> 00:00:12,400 THIS AD HOC MEETING OF THE NIH 3 00:00:12,400 --> 00:00:13,600 ADVISORY COMMITTEE TO THE 4 00:00:13,600 --> 00:00:16,200 DIRECTOR. 5 00:00:16,200 --> 00:00:18,480 WE REALLY APPRECIATE YOU TAKING 6 00:00:18,480 --> 00:00:20,280 TIME OUT OF WHAT I'M SURE ARE 7 00:00:20,280 --> 00:00:22,880 VERY BUSY SCHEDULES TO BE WITH 8 00:00:22,880 --> 00:00:26,280 US TODAY, IN ADDITION TO THE 9 00:00:26,280 --> 00:00:27,360 MEETING THAT WE HAVE SCHEDULED 10 00:00:27,360 --> 00:00:29,520 IN DECEMBER. 11 00:00:29,520 --> 00:00:31,520 WE HAD A SERIES OF VERY 12 00:00:31,520 --> 00:00:35,120 IMPORTANT TOPICS TO DISCUSS IN 13 00:00:35,120 --> 00:00:37,760 THE DECEMBER MEETING, AND 14 00:00:37,760 --> 00:00:40,240 THOUGHT THAT THERE WOULD BE 15 00:00:40,240 --> 00:00:43,120 BENEFIT IN PROVIDING YOU WITH A 16 00:00:43,120 --> 00:00:45,000 PREVIEW OF THESE TOPICS THIS 17 00:00:45,000 --> 00:00:47,600 EVENING, HENCE THIS SPECIAL AD 18 00:00:47,600 --> 00:00:50,000 HOC MEETING. 19 00:00:50,000 --> 00:00:52,840 AS A REMINDER, THE MEETING WILL 20 00:00:52,840 --> 00:00:56,560 RUN FROM 5:00 P.M. TO 6:00 P.M. 21 00:00:56,560 --> 00:01:00,520 TODAY, AND WILL BE RECORDED. 22 00:01:00,520 --> 00:01:02,040 TO HELP US STAY ON TIME, I'VE 23 00:01:02,040 --> 00:01:04,920 ASKED THE NIH ACTING PRINCIPAL 24 00:01:04,920 --> 00:01:09,240 DEPUTY DIRECTOR, DR. TARA 25 00:01:09,240 --> 00:01:12,400 SCHWETZ, TO MONITOR THE TIME. 26 00:01:12,400 --> 00:01:14,600 SHE HAS A BELL, I GUESS, THAT 27 00:01:14,600 --> 00:01:16,680 WILL BE USED AS A SIGNAL, AND 28 00:01:16,680 --> 00:01:19,960 SHE WILL GO OVER A FEW 29 00:01:19,960 --> 00:01:23,040 LOGISTICAL ITEMS FOR YOU. 30 00:01:23,040 --> 00:01:23,240 TARA? 31 00:01:23,240 --> 00:01:24,440 >>THANKS, LARRY. 32 00:01:24,440 --> 00:01:25,680 I DON'T KNOW IF THE BELL WILL 33 00:01:25,680 --> 00:01:26,240 WORK. 34 00:01:26,240 --> 00:01:28,280 WE'LL TRY IT AND SEE. 35 00:01:28,280 --> 00:01:30,040 SOMETIMES THE SOUND SORT OF 36 00:01:30,040 --> 00:01:33,880 MUFFLES IT OUT, BUT HERE WE GO. 37 00:01:33,880 --> 00:01:34,840 DID WE HEAR THAT? 38 00:01:34,840 --> 00:01:35,120 >>NO. 39 00:01:35,120 --> 00:01:35,920 >>OKAY. 40 00:01:35,920 --> 00:01:40,120 SO WE'LL DO IT BY PINGING IN THE 41 00:01:40,120 --> 00:01:40,400 CHAT. 42 00:01:40,400 --> 00:01:42,680 THAT WILL BE THE APPROACH. 43 00:01:42,680 --> 00:01:44,240 SO JUST A FEW REMINDERS FOR 44 00:01:44,240 --> 00:01:44,720 FOLKS. 45 00:01:44,720 --> 00:01:47,120 THE MEETING IS OPEN TO THE 46 00:01:47,120 --> 00:01:48,520 PUBLIC, INCLUDING MEMBERS OF THE 47 00:01:48,520 --> 00:01:52,240 PRESS AND IT IS BEING WEBCAST. 48 00:01:52,240 --> 00:01:53,240 MEETING PRESENTATIONS AND ANY OF 49 00:01:53,240 --> 00:01:55,520 THE SUPPLEMENTAL MATERIALS ARE 50 00:01:55,520 --> 00:01:57,960 POSTED ON THE ACD -- OR WILL BE 51 00:01:57,960 --> 00:01:59,480 POSTED ON THE ACD WEBSITE AFTER 52 00:01:59,480 --> 00:02:01,080 THE MEETING. 53 00:02:01,080 --> 00:02:02,560 AND THIS MEETING WAS ANNOUNCED 54 00:02:02,560 --> 00:02:04,600 IN THE FEDERAL REGISTER ON 55 00:02:04,600 --> 00:02:06,640 OCTOBER 26TH OF 2022. 56 00:02:06,640 --> 00:02:08,960 OF NOTE, WE DID RECEIVE PUBLIC 57 00:02:08,960 --> 00:02:10,840 COMMENT AND ACD MEMBERS CAN 58 00:02:10,840 --> 00:02:13,240 REVIEW IT ON THE SHARE FILE SITE 59 00:02:13,240 --> 00:02:15,120 AND YOU RECEIVED AN EMAIL ABOUT 60 00:02:15,120 --> 00:02:19,240 THIS MAYBE ABOUT AN HOUR AGO OR 61 00:02:19,240 --> 00:02:20,360 SO. 62 00:02:20,360 --> 00:02:21,800 ACD MEMBERS AND PRESENTERS ARE 63 00:02:21,800 --> 00:02:22,880 USING THE ZOOM APPLICATION TO 64 00:02:22,880 --> 00:02:24,280 CONDUCT THE MEETING TODAY, AND 65 00:02:24,280 --> 00:02:26,480 YOU CAN USE THE CHAT FEATURE TO 66 00:02:26,480 --> 00:02:29,760 POSE QUESTIONS, AND MAKE A 67 00:02:29,760 --> 00:02:33,120 COMMENT OR ASK A QUESTION. 68 00:02:33,120 --> 00:02:36,520 AS I MENTIONED, I WILL PING THE 69 00:02:36,520 --> 00:02:38,840 PRESENTERS WHEN TIME IS UP, SO 70 00:02:38,840 --> 00:02:41,120 PLEASE MONITOR FOR THAT AS WELL. 71 00:02:41,120 --> 00:02:44,080 NOW WHEN AN ACD MEMBER DOES WISH 72 00:02:44,080 --> 00:02:45,840 TO MAKE A COMMENT, WE ASK THAT 73 00:02:45,840 --> 00:02:47,480 YOU PLEASE RAISE YOUR DIGITAL 74 00:02:47,480 --> 00:02:49,360 HAND AND TURN ON YOUR VIDEO AND 75 00:02:49,360 --> 00:02:51,320 MIC SO THAT WE CAN SEE YOUR 76 00:02:51,320 --> 00:02:52,080 FACE. 77 00:02:52,080 --> 00:02:53,920 AND SO WE ARE RECORDING MORE 78 00:02:53,920 --> 00:02:55,880 THAN JUST THE BOX WITH YOUR NAME 79 00:02:55,880 --> 00:02:59,280 ON IT. 80 00:02:59,280 --> 00:03:01,280 I'LL TURN IT BACK TO LARRY FOR 81 00:03:01,280 --> 00:03:02,800 GOING THROUGH THE AGENDA TODAY. 82 00:03:02,800 --> 00:03:04,080 >>OKAY, GREAT. 83 00:03:04,080 --> 00:03:06,280 THANK YOU VERY MUCH, TARA. 84 00:03:06,280 --> 00:03:07,600 SO I HAVE BEEN INFORMED THAT WE 85 00:03:07,600 --> 00:03:10,080 HAVE A QUORUM. 86 00:03:10,080 --> 00:03:12,400 BEFORE WE BEGIN OUR FIRST 87 00:03:12,400 --> 00:03:14,600 PRESENTATION, I DID WANT TO 88 00:03:14,600 --> 00:03:17,320 SHARE THAT CURRENT NIH ACD 89 00:03:17,320 --> 00:03:20,080 MEMBERS NOW HAVE ACCESS TO THE 90 00:03:20,080 --> 00:03:22,360 CENTER FOR SCIENTIFIC REVIEW'S 91 00:03:22,360 --> 00:03:24,440 BIAS AWARENESS AND MITIGATION 92 00:03:24,440 --> 00:03:26,200 AND TRAINING FOR REVIEWERS, 93 00:03:26,200 --> 00:03:28,040 WHICH WAS LAUNCHED LAST FALL, 94 00:03:28,040 --> 00:03:30,360 AND WE WILL SHARE THE 95 00:03:30,360 --> 00:03:31,760 INFORMATION WITH THE ACD MEMBERS 96 00:03:31,760 --> 00:03:33,520 ON HOW TO ACCESS THE TRAINING 97 00:03:33,520 --> 00:03:36,680 AFTER THIS MEETING. 98 00:03:36,680 --> 00:03:40,400 THIS EVENING, WE WILL HEAR 99 00:03:40,400 --> 00:03:43,360 PRESENTATIONS FROM DR. NONI 100 00:03:43,360 --> 00:03:44,680 BYRNES, DIRECTOR OF THE CENTER 101 00:03:44,680 --> 00:03:46,000 FOR SCIENTIFIC REVIEW, ON A 102 00:03:46,000 --> 00:03:48,520 PROPOSED NEW FRAMEWORK FOR PEER 103 00:03:48,520 --> 00:03:48,960 REVIEW CRITERIA. 104 00:03:48,960 --> 00:03:52,680 WE WILL THEN TURN TO DR. SHELLEY 105 00:03:52,680 --> 00:03:55,720 BERGER, ACD MEMBER, AND 106 00:03:55,720 --> 00:03:56,440 UNIVERSITY PROFESSOR AT 107 00:03:56,440 --> 00:03:59,560 UNIVERSITY OF PENNSYLVANIA, AND 108 00:03:59,560 --> 00:04:00,560 DR. TARA SCHWETZ, WHO YOU'VE 109 00:04:00,560 --> 00:04:03,040 ALREADY HEARD FROM, ACTING 110 00:04:03,040 --> 00:04:04,600 PRINCIPAL DEPUTY DIRECTOR AT 111 00:04:04,600 --> 00:04:07,240 NIH, ON A PROPOSED ACD WORKING 112 00:04:07,240 --> 00:04:08,840 GROUP ON POSTDOCS. 113 00:04:08,840 --> 00:04:12,480 AND THEN FINALLY, A PRESENTATION 114 00:04:12,480 --> 00:04:15,200 BY DRS. HOWARD CHANG, PROFESSOR 115 00:04:15,200 --> 00:04:17,360 OF CANCER RESEARCH AND GENETICS 116 00:04:17,360 --> 00:04:20,000 AT STANFORD, AND DR. LYRIC 117 00:04:20,000 --> 00:04:21,440 JORGENSON, WHO IS THE ACTING 118 00:04:21,440 --> 00:04:23,080 ASSOCIATE DIRECTOR FOR SCIENCE 119 00:04:23,080 --> 00:04:25,280 POLICY AT NIH, AND THEN AT THE 120 00:04:25,280 --> 00:04:26,680 VERY END, WE'LL JUST HAVE SOME 121 00:04:26,680 --> 00:04:28,440 CLOSING REMARKS TO MAKE. 122 00:04:28,440 --> 00:04:29,960 SO WITH THAT, I'M GOING TO TURN 123 00:04:29,960 --> 00:04:33,240 IT BACK TO DR. SCHWETZ, WHO WILL 124 00:04:33,240 --> 00:04:36,200 LEAD US THROUGH THE AGENDA. 125 00:04:36,200 --> 00:04:41,040 SO THANKS. 126 00:04:41,040 --> 00:04:42,840 >>THANKS, LARRY. 127 00:04:42,840 --> 00:04:46,880 I'M GOING TO TURN IT OVER TO DRY 128 00:04:46,880 --> 00:04:48,000 MENTIONED IS THE DIRECTOR OF THE 129 00:04:48,000 --> 00:04:51,280 CENTER FOR SCIENTIFIC REVIEW 130 00:04:51,280 --> 00:04:52,440 WHO'S GOING TO WALK THROUGH A 131 00:04:52,440 --> 00:04:54,160 PROPOSED NEW FRAMEWORK FOR PEER 132 00:04:54,160 --> 00:04:56,520 REVIEW CRITERIA. 133 00:04:56,520 --> 00:05:00,960 SO NONI, TO YOU. 134 00:05:00,960 --> 00:05:02,360 >>THANKS, TARA. 135 00:05:02,360 --> 00:05:03,800 I JUST WANT TO SAY I CAN'T 136 00:05:03,800 --> 00:05:07,640 REALLY SEE CHAT WHEN I'M IN 137 00:05:07,640 --> 00:05:08,840 FULL SCREEN, SO IF YOU WANT TO 138 00:05:08,840 --> 00:05:11,240 RING THE BELL, YOU CAN JUST 139 00:05:11,240 --> 00:05:12,800 INTERRUPT. 140 00:05:12,800 --> 00:05:14,000 WHILE I'M SPEAKING. 141 00:05:14,000 --> 00:05:16,160 OKAY, THANK YOU, EVERYONE. 142 00:05:16,160 --> 00:05:17,440 IT'S GREAT TO BE HERE. 143 00:05:17,440 --> 00:05:20,880 AND I WANT TO SHARE WITH YOU A 144 00:05:20,880 --> 00:05:22,920 PROPOSED FRAMEWORK FOR PEER 145 00:05:22,920 --> 00:05:25,040 REVIEW CRITERIA THAT WAS 146 00:05:25,040 --> 00:05:28,960 DEVELOPED BASED ON ADVICE FROM A 147 00:05:28,960 --> 00:05:31,040 CSR ADVISORY COUNCIL WORKING 148 00:05:31,040 --> 00:05:31,600 GROUP. 149 00:05:31,600 --> 00:05:32,480 I'LL TELL YOU A LITTLE BIT MORE 150 00:05:32,480 --> 00:05:35,960 ABOUT HOW THE DEVELOPMENT 151 00:05:35,960 --> 00:05:36,840 OCCURRED, AND THEN WENT THROUGH 152 00:05:36,840 --> 00:05:38,240 THE NIH PROCESS. 153 00:05:38,240 --> 00:05:44,160 SO LET ME START WITH A 154 00:05:44,160 --> 00:05:44,600 BACKGROUND. 155 00:05:44,600 --> 00:05:46,680 IT'S JUST A REMINDER, WHICH I 156 00:05:46,680 --> 00:05:48,000 THINK ALL OF YOU ARE QUITE 157 00:05:48,000 --> 00:05:49,520 FAMILIAR WITH, WHICH IS THAT NIH 158 00:05:49,520 --> 00:05:55,000 HAS A UNIQUE TWO-LEVEL PEER 159 00:05:55,000 --> 00:05:55,640 REVIEW SYSTEM. 160 00:05:55,640 --> 00:05:58,160 THE FIRST LEVEL IS AT THE STUDY 161 00:05:58,160 --> 00:05:59,600 SECTION OR SEP AND THE SECOND 162 00:05:59,600 --> 00:06:01,880 LEVEL OF REVIEW OCCURS AT THE IC 163 00:06:01,880 --> 00:06:02,640 ADVISORY COUNCIL. 164 00:06:02,640 --> 00:06:04,320 AND THE GOAL OF THE FIRST LEVEL 165 00:06:04,320 --> 00:06:05,960 OF PEER REVIEW IS VERY SINGULAR. 166 00:06:05,960 --> 00:06:07,920 IT'S TO PROVIDE EXPERT ADVICE TO 167 00:06:07,920 --> 00:06:10,760 THE AGENCY ON THE SCIENTIFIC AND 168 00:06:10,760 --> 00:06:12,320 TECHNICAL MERIT OF GRANT 169 00:06:12,320 --> 00:06:16,760 APPLICATIONS. 170 00:06:16,760 --> 00:06:18,720 SO WE HAVE TWO MAIN DRIVERS FOR 171 00:06:18,720 --> 00:06:20,240 THINKING ABOUT PEER REVIEW 172 00:06:20,240 --> 00:06:22,320 CRITERIA, AND THE WAY THIS WENT 173 00:06:22,320 --> 00:06:26,840 IS, WE STARTED WITH THE FIRST 174 00:06:26,840 --> 00:06:28,880 RATIONALE FOR LOOKING AT REVIEW 175 00:06:28,880 --> 00:06:29,880 CRITERIA, AND THEN AS WE 176 00:06:29,880 --> 00:06:32,840 GATHERED MORE INPUT INTO THE 177 00:06:32,840 --> 00:06:34,120 PROCESS, THE SECOND ONE. 178 00:06:34,120 --> 00:06:36,040 SO THE FIRST ONE IS EXPANSION OF 179 00:06:36,040 --> 00:06:37,520 REVIEWER DUTIES THAT WENT BEYOND 180 00:06:37,520 --> 00:06:39,560 THE GOALS OF THE FIRST-LEVEL 181 00:06:39,560 --> 00:06:41,160 PEER REVIEW, AND THE SECOND 182 00:06:41,160 --> 00:06:43,840 DRIVER IS REDUCING BIAS IN THE 183 00:06:43,840 --> 00:06:45,640 PEER REVIEW PROCESS, AND THAT 184 00:06:45,640 --> 00:06:47,720 SECOND ONE CAME ABOUT SORT OF AS 185 00:06:47,720 --> 00:06:51,560 WE GATHERED INPUT INTO 186 00:06:51,560 --> 00:06:54,400 RESTRUCTURING REVIEW. 187 00:06:54,400 --> 00:06:55,680 SO LET'S START WITH THE FIRST 188 00:06:55,680 --> 00:06:56,040 ONE. 189 00:06:56,040 --> 00:06:58,520 WHAT DOES THAT MEAN? 190 00:06:58,520 --> 00:07:00,720 SO TALKED ABOUT THE GOAL OF PEER 191 00:07:00,720 --> 00:07:02,680 REVIEW, AND NIH VERY MUCH RELIES 192 00:07:02,680 --> 00:07:06,720 ON THE EXPERTISE OF STUDY 193 00:07:06,720 --> 00:07:08,600 SECTION TO IDENTIFY HIGH IMPACT 194 00:07:08,600 --> 00:07:09,040 RESEARCH. 195 00:07:09,040 --> 00:07:11,000 BUT OVER TIME, OVER THE LAST 196 00:07:11,000 --> 00:07:13,640 DECADE, MORE THAN A DECADE, 197 00:07:13,640 --> 00:07:17,440 INCREMENTALLY WITH GOOD 198 00:07:17,440 --> 00:07:18,640 INTENTIONS, NIH SCIENTIFIC PEER 199 00:07:18,640 --> 00:07:19,560 REVIEWERS HAVE BEEN ASKED TO 200 00:07:19,560 --> 00:07:23,000 TAKE ON OTHER FUNCTIONS. 201 00:07:23,000 --> 00:07:23,600 MORE ADMINISTRATIVE CHECKS, 202 00:07:23,600 --> 00:07:25,360 THINGS THAT ARE IMPORTANT. 203 00:07:25,360 --> 00:07:27,000 POLICY COMPLIANCE, CULTURE 204 00:07:27,000 --> 00:07:27,960 CHANGE. 205 00:07:27,960 --> 00:07:31,360 AND WE CAN TALK ABOUT WHETHER OR 206 00:07:31,360 --> 00:07:32,800 NOT PEER REVIEW -- PEER REVIEW 207 00:07:32,800 --> 00:07:34,200 ACTUALLY IS NOT A GOOD SYSTEM, 208 00:07:34,200 --> 00:07:35,640 IT'S NOT SET UP TO DO THESE 209 00:07:35,640 --> 00:07:37,880 KINDS OF REVIEWS, AND SO IT'S 210 00:07:37,880 --> 00:07:38,680 NOT NECESSARILY GOOD FOR THE 211 00:07:38,680 --> 00:07:40,760 NIH, BUT FROM THE REVIEWERS' 212 00:07:40,760 --> 00:07:41,880 PERSPECTIVE, THERE ARE A COUPLE 213 00:07:41,880 --> 00:07:44,120 OF CONSEQUENCES. 214 00:07:44,120 --> 00:07:45,760 ONE IS REVIEWER BURDEN. 215 00:07:45,760 --> 00:07:47,560 WE HAVE VOLUNTEER REVIEWERS, WE 216 00:07:47,560 --> 00:07:49,360 RECRUIT THEM BASED ON THEIR 217 00:07:49,360 --> 00:07:51,920 SCIENTIFIC EXPERTISE. 218 00:07:51,920 --> 00:07:54,640 THEY HAVE -- THEY PREPARE EIGHT 219 00:07:54,640 --> 00:07:55,960 TO 10 APPLICATIONS AND THEN THEY 220 00:07:55,960 --> 00:07:57,920 HAVE AROUND 20 MINUTES AT THE 221 00:07:57,920 --> 00:07:59,560 MEETING TO TELL US ABOUT WHAT 222 00:07:59,560 --> 00:08:01,000 THEY THINK ABOUT THE SCIENCE AND 223 00:08:01,000 --> 00:08:02,200 THE IMPACT. 224 00:08:02,200 --> 00:08:04,160 AND THERE'S A CERTAIN LIMITATION 225 00:08:04,160 --> 00:08:05,400 OF BANDWIDTH THAT OCCURS THAT 226 00:08:05,400 --> 00:08:08,760 CAN AFFECT THE QUALITY OF THE 227 00:08:08,760 --> 00:08:09,960 SCIENTIFIC INPUT BECAUSE OF ALL 228 00:08:09,960 --> 00:08:12,960 THE OTHER DISTRACTIONS THAT 229 00:08:12,960 --> 00:08:14,440 WE'RE ASKING THEM TO TAKE CARE. 230 00:08:14,440 --> 00:08:16,400 THE OTHER PART RELATED TO THAT 231 00:08:16,400 --> 00:08:18,840 IIS REVIEWER RECRUITMENT. 232 00:08:18,840 --> 00:08:24,080 SO ONE THING THAT OUR STAFF HERE 233 00:08:24,080 --> 00:08:25,600 IS -- REVIEWER SCIENTISTS LIKE 234 00:08:25,600 --> 00:08:26,800 COMING AND TALKING ABOUT THE 235 00:08:26,800 --> 00:08:28,560 SCIENCE AND GIVING -- BASICALLY 236 00:08:28,560 --> 00:08:30,400 DOING THAT PART OF THE ROLE, BUT 237 00:08:30,400 --> 00:08:32,920 THE ADMINISTRATIVE BURDEN CAN BE 238 00:08:32,920 --> 00:08:35,120 A DISINCENTIVE TO SERVE. 239 00:08:35,120 --> 00:08:36,640 SO WE KNOW OUR STAFF HAVE HEARD 240 00:08:36,640 --> 00:08:38,040 THAT, I'VE HEARD IT. 241 00:08:38,040 --> 00:08:42,120 AND NIH LEADERSHIP HAS HEARD IT. 242 00:08:42,120 --> 00:08:43,680 AND EARLIER THIS YEAR, THERE WAS 243 00:08:43,680 --> 00:08:45,880 AN EMAIL THAT'S JUST ONE EXAMPLE 244 00:08:45,880 --> 00:08:49,680 OF THE KINDS OF FEEDBACK WE HEAR 245 00:08:49,680 --> 00:08:51,200 RELATED TO BURDEN IN REVIEW. 246 00:08:51,200 --> 00:08:53,160 AND THIS WAS SENT TO LARRY AND 247 00:08:53,160 --> 00:08:55,160 COPIED TO ME, BUT YOU KNOW, IT 248 00:08:55,160 --> 00:08:57,720 REALLY PUTS IT VERY WELL. 249 00:08:57,720 --> 00:08:59,080 AND THIS, I'LL CALL YOUR 250 00:08:59,080 --> 00:09:01,160 ATTENTION TO THIS LAST SENTENCE 251 00:09:01,160 --> 00:09:02,360 HERE, "SHOULDN'T THE PRECIOUS 252 00:09:02,360 --> 00:09:04,080 TIME OF VOLUNTEER REVIEWERS BE 253 00:09:04,080 --> 00:09:06,160 FOCUSED ON THE CRITICAL 254 00:09:06,160 --> 00:09:13,840 EVALUATION OF SCIENCE?" 255 00:09:13,840 --> 00:09:15,480 SO THE SECOND PART OF OUR 256 00:09:15,480 --> 00:09:19,200 RATIONALE WAS REDUCING BIAS, AND 257 00:09:19,200 --> 00:09:20,840 WE HAVE -- WE'VE HEARD COMMUNITY 258 00:09:20,840 --> 00:09:22,200 CONCERNS THROUGH THIS PROCESS, 259 00:09:22,200 --> 00:09:25,120 THROUGH OTHER PROCESSES. 260 00:09:25,120 --> 00:09:27,160 SO NIH AND CSR LEADERSHIP HAVE 261 00:09:27,160 --> 00:09:28,720 HEARD COMMUNITY CONCERNS, AND 262 00:09:28,720 --> 00:09:30,720 THE FOCUS MOSTLY IS ON 263 00:09:30,720 --> 00:09:31,880 REPUTATIONAL BIAS IN PEER 264 00:09:31,880 --> 00:09:32,360 REVIEW. 265 00:09:32,360 --> 00:09:34,400 IF YOU'VE BEEN INVOLVED IN ANY 266 00:09:34,400 --> 00:09:36,440 ASPECT IN PEER REVIEW, AS AN 267 00:09:36,440 --> 00:09:39,760 APPLICANT, AS A REVIEWER, AS NIH 268 00:09:39,760 --> 00:09:41,840 STAFF, YOU'VE SEEN THAT THIS 269 00:09:41,840 --> 00:09:43,160 OCCURS IN STUDY SECTIONS. 270 00:09:43,160 --> 00:09:46,000 SO WE'VE HEARD THIS FROM 271 00:09:46,000 --> 00:09:48,240 SOLICITED FEEDBACK, SO WE HAD 272 00:09:48,240 --> 00:09:49,600 BROAD SOLICITED FEEDBACK FOR 273 00:09:49,600 --> 00:09:51,120 THIS SIMPLIFYING REVIEW PROCESS, 274 00:09:51,120 --> 00:09:52,320 JUST ASKING THE COMMUNITY FOR 275 00:09:52,320 --> 00:09:54,200 THEIR INPUT. 276 00:09:54,200 --> 00:09:55,600 CSR RECENTLY RELEASED A 277 00:09:55,600 --> 00:09:56,520 STRATEGIC PLAN AND WE WENT 278 00:09:56,520 --> 00:09:57,920 THROUGH A FEEDBACK PROCESS 279 00:09:57,920 --> 00:09:58,760 THERE. 280 00:09:58,760 --> 00:10:00,440 AND WE HEARD THIS CONCERN COME 281 00:10:00,440 --> 00:10:03,960 UP REPEATEDLY IN BOTH SETTINGS. 282 00:10:03,960 --> 00:10:06,120 WE HEAR UNSOLICITED FEEDBACK, 283 00:10:06,120 --> 00:10:07,000 JUST DIRECT COMMUNICATIONS THAT 284 00:10:07,000 --> 00:10:11,800 COME TO LEADERSHIP, YOU KNOW, 285 00:10:11,800 --> 00:10:13,440 FORMER MEMBER OR CURRENT MEMBER 286 00:10:13,440 --> 00:10:18,240 OF THE ACD HAD RAISED THIS 287 00:10:18,240 --> 00:10:21,240 CONCERN ABOUT INSTITUTIONAL BIAS 288 00:10:21,240 --> 00:10:23,280 TO FRANCIS AND TO LARRY, AND 289 00:10:23,280 --> 00:10:25,040 ACTUALLY WE ASKED HIM TO DO A 290 00:10:25,040 --> 00:10:26,680 TESTIMONIAL IN THE CSR BIAS 291 00:10:26,680 --> 00:10:27,720 TRAINING WHICH HE DID, WHICH I 292 00:10:27,720 --> 00:10:31,600 THINK IS REALLY EFFECTIVE AND 293 00:10:31,600 --> 00:10:32,600 MOVING, SO HOPE YOU HAVE A 294 00:10:32,600 --> 00:10:33,480 CHANCE TO SEE THAT. 295 00:10:33,480 --> 00:10:35,560 I'VE HAD FEEDBACK THROUGH 296 00:10:35,560 --> 00:10:39,720 COUNCIL DISCUSSIONS I'VE HAD IN 297 00:10:39,720 --> 00:10:41,920 OUR SUMMER CHAIR ORIENTATIONS, 298 00:10:41,920 --> 00:10:43,200 THIS WAS RAISED AS A CONCERN. 299 00:10:43,200 --> 00:10:45,080 THE CSR ADVISORY COUNCIL WORKING 300 00:10:45,080 --> 00:10:46,200 GROUP THAT WOULD HE FORMED, SO 301 00:10:46,200 --> 00:10:47,640 WE DO A LOT OF OUR INITIATIVES 302 00:10:47,640 --> 00:10:50,520 THROUGH WORKING GROUPS, SORT OF 303 00:10:50,520 --> 00:10:51,880 LIKE THE ACD WITH THE ADVISORY 304 00:10:51,880 --> 00:10:53,160 COUNCIL WORKING GROUP TO GET 305 00:10:53,160 --> 00:10:54,560 COMMUNITY INPUT, AND WE HAD SUCH 306 00:10:54,560 --> 00:10:56,680 A WORKING GROUP WHICH IS PRETTY 307 00:10:56,680 --> 00:10:58,200 DIVERSE PUT TOGETHER TO ADVISE 308 00:10:58,200 --> 00:11:00,640 US ON DEVELOPING THE CONTENT FOR 309 00:11:00,640 --> 00:11:01,800 THIS BIAS TRAINING THAT WAS 310 00:11:01,800 --> 00:11:03,120 LAUNCHED LAST YEAR, AND THEY 311 00:11:03,120 --> 00:11:05,200 ENDED UP ZEROING IN ON 312 00:11:05,200 --> 00:11:07,400 REPUTATIONAL BIAS AS A MAJOR 313 00:11:07,400 --> 00:11:10,000 SOURCE OF BYE-BYE AS IN PEER 314 00:11:10,000 --> 00:11:13,440 REVIEW. 315 00:11:13,440 --> 00:11:15,360 SO IN ADDITION TO FEEDBACK, THE 316 00:11:15,360 --> 00:11:16,600 FEEDBACK THAT WE HEARD IS 317 00:11:16,600 --> 00:11:20,280 ACTUALLY SUPPORTED BY SOME 318 00:11:20,280 --> 00:11:22,040 STUDIES AND WE ARE TAKING 319 00:11:22,040 --> 00:11:24,240 MULTIPRONGED ACTIONS, AND THIS 320 00:11:24,240 --> 00:11:25,360 RESTRUCTURING OF PEER REVIEW IS 321 00:11:25,360 --> 00:11:25,760 ONE OF THEM. 322 00:11:25,760 --> 00:11:29,280 SO JUST A QUICK UPDATE ON THE 323 00:11:29,280 --> 00:11:30,560 CSR ANONYMIZATION STUDY THAT I'M 324 00:11:30,560 --> 00:11:31,760 SURE THIS GROUP IS FAMILIAR WITH 325 00:11:31,760 --> 00:11:33,520 THAT WAS LAUNCHED MANY YEARS 326 00:11:33,520 --> 00:11:39,640 AGO, IT WAS PUBLISHED LAST YEAR 327 00:11:39,640 --> 00:11:42,160 AND THIS INVOLVED REDACTING THE 328 00:11:42,160 --> 00:11:43,760 IDENTIFIERS OF PIs AND 329 00:11:43,760 --> 00:11:45,120 INSTITUTIONS IN GRANT 330 00:11:45,120 --> 00:11:45,440 APPLICATIONS. 331 00:11:45,440 --> 00:11:48,400 SO THE BOTTOM LINE OF THE STUDY, 332 00:11:48,400 --> 00:11:51,440 THE MAIN QUESTION WAS WHETHER 333 00:11:51,440 --> 00:11:52,640 REDACTING IDENTIFIERS WOULD 334 00:11:52,640 --> 00:11:54,520 IMPROVE THE SCORE OF BLACK 335 00:11:54,520 --> 00:11:56,400 APPLICANT, IT DIDN'T DO THAT. 336 00:11:56,400 --> 00:12:00,000 IT DID, HOWEVER, INTERESTINGLY, 337 00:12:00,000 --> 00:12:02,440 WORSENED A SMALL EFFECT SIZE BUT 338 00:12:02,440 --> 00:12:04,040 STILL SIGNIFICANT, WORSENED THE 339 00:12:04,040 --> 00:12:05,280 SCORES FOR WHITE APPLICANTS, 340 00:12:05,280 --> 00:12:06,320 WHICH MEANT THAT THERE WAS SOME 341 00:12:06,320 --> 00:12:07,880 LEVEL OF A BUMP THAT WHITE 342 00:12:07,880 --> 00:12:09,920 APPLICANTS WERE ENJOYING JUST 343 00:12:09,920 --> 00:12:11,560 BASED ON THEIR NAME RECOGNITION 344 00:12:11,560 --> 00:12:14,240 OR THE INSTITUTION THEY WERE IN. 345 00:12:14,240 --> 00:12:15,520 AROUND 20% OF THE TIME, 346 00:12:15,520 --> 00:12:17,360 REVIEWERS COULD IDENTIFY THE 347 00:12:17,360 --> 00:12:18,760 APPLICANT, AND THAT, I THINK IS 348 00:12:18,760 --> 00:12:20,560 NOT UNEXPECTED AND ONE OF THE 349 00:12:20,560 --> 00:12:23,520 ISSUES WE HAVE WITH AN 350 00:12:23,520 --> 00:12:24,400 ANONYMIZED REVIEW PROCESS IN 351 00:12:24,400 --> 00:12:25,000 SCIENCE. 352 00:12:25,000 --> 00:12:26,360 IT'S HARD TO ANONYMIZE BECAUSE 353 00:12:26,360 --> 00:12:27,680 PEOPLE KNOW EACH OTHER AND WHAT 354 00:12:27,680 --> 00:12:29,000 THEY'RE DOING. 355 00:12:29,000 --> 00:12:31,480 SO WHAT DOES THIS MEAN? 356 00:12:31,480 --> 00:12:32,680 DOES THIS MEAN WE CAN SORT OF 357 00:12:32,680 --> 00:12:34,080 HANG IT UP, THERE'S NO BIAS? 358 00:12:34,080 --> 00:12:35,680 DEFINITELY NOT. 359 00:12:35,680 --> 00:12:37,480 THE TWO TAKEAWAYS THAT WE GOT 360 00:12:37,480 --> 00:12:39,800 FROM THIS WAS THAT FIRST OF ALL 361 00:12:39,800 --> 00:12:42,120 IT'S NOT SO EASY TO HAVE RACE AS 362 00:12:42,120 --> 00:12:43,640 A SINGLE VARIABLE. 363 00:12:43,640 --> 00:12:46,000 RACE IS VERY TIGHTLY LINKED TO 364 00:12:46,000 --> 00:12:47,160 OTHER VARIABLES. 365 00:12:47,160 --> 00:12:49,960 IT'S LINKED TO DISPARITIES AND 366 00:12:49,960 --> 00:12:54,360 OPPORTUNITY AND ACCESS, AND SO 367 00:12:54,360 --> 00:12:55,400 THAT'S SOMETHING WE NEED TO 368 00:12:55,400 --> 00:12:56,400 THINK CAREFULLY ABOUT. 369 00:12:56,400 --> 00:12:59,000 AND THE FINDINGS DO SUPPORT THE 370 00:12:59,000 --> 00:13:01,360 IDEA THAT WE SHOULD EXAMINE 371 00:13:01,360 --> 00:13:04,280 APPROACHES AND REVIEW THAT 372 00:13:04,280 --> 00:13:05,960 DIMINISH THE ROLE OF P.I. 373 00:13:05,960 --> 00:13:08,360 IDENTITY AND INSTITUTIONAL 374 00:13:08,360 --> 00:13:10,520 IDENTITY. 375 00:13:10,520 --> 00:13:12,280 AND JUST VERY QUICKLY, 376 00:13:12,280 --> 00:13:13,680 RESTRUCTURING REVIEW CRITERIA IS 377 00:13:13,680 --> 00:13:15,240 ONE ASPECT THAT I'LL BE TALKING 378 00:13:15,240 --> 00:13:16,880 ABOUT TODAY AND THEN AGAIN IN 379 00:13:16,880 --> 00:13:18,960 MORE DETAIL IN DECEMBER, BUT CSR 380 00:13:18,960 --> 00:13:20,920 HAS A NUMBER OF CONCURRENT 381 00:13:20,920 --> 00:13:22,440 INITIATIVES THAT WE'RE TACKLING 382 00:13:22,440 --> 00:13:25,440 THIS FROM DIFFERENT ANGLES. 383 00:13:25,440 --> 00:13:27,160 THE TRAINING, WE HAVE REPORTING 384 00:13:27,160 --> 00:13:29,240 AVENUES WE'RE TRYING TO BROADEN 385 00:13:29,240 --> 00:13:31,160 WITH SOME SUCCESS THE REVIEW 386 00:13:31,160 --> 00:13:33,400 POOL AND WE'RE ALSO TRYING OUT 387 00:13:33,400 --> 00:13:33,920 SOME ANONYMIZED REVIEW 388 00:13:33,920 --> 00:13:38,200 PROCESSES. 389 00:13:38,200 --> 00:13:40,480 SO WALK YOU THROUGH THE PROCESS. 390 00:13:40,480 --> 00:13:42,800 IN JANUARY OF 2020, WE CONVENED 391 00:13:42,800 --> 00:13:44,760 A CSR ADVISORY COUNCIL WORKING 392 00:13:44,760 --> 00:13:46,200 GROUP ON SIMPLIFYING REVIEW. 393 00:13:46,200 --> 00:13:48,640 AND AT THAT POINT, OUR FOCUS WAS 394 00:13:48,640 --> 00:13:50,000 NOT NECESSARILY ON BIAS. 395 00:13:50,000 --> 00:13:54,360 IT WAS JUST ON TRYING TO GET 396 00:13:54,360 --> 00:13:56,000 REVIEW CRITERIA SIMPLIFIED AND 397 00:13:56,000 --> 00:13:56,480 REDUCE BURDEN. 398 00:13:56,480 --> 00:13:58,760 THE SCOPE WAS RPGs, RESEARCH 399 00:13:58,760 --> 00:14:00,200 PROJECT GRANTS, WHICH IS MOST OF 400 00:14:00,200 --> 00:14:01,800 WHAT CSR DOES. 401 00:14:01,800 --> 00:14:03,680 THE GROUP WAS ASSEMBLED AND 402 00:14:03,680 --> 00:14:06,200 DECIDED THAT THEY WOULD START 403 00:14:06,200 --> 00:14:07,920 WITH THE NON-CLINICAL TRIALS, 404 00:14:07,920 --> 00:14:10,600 WHICH ARE ABOUT 90% OF NIH 405 00:14:10,600 --> 00:14:11,840 APPLICATIONS, BECAUSE CLINICAL 406 00:14:11,840 --> 00:14:13,280 TRIALS ADD A LEVEL OF COMPLEXITY 407 00:14:13,280 --> 00:14:15,000 AND THEY WANTED ADDITIONAL 408 00:14:15,000 --> 00:14:15,800 EXPERTISE ON THE WORKING GROUP 409 00:14:15,800 --> 00:14:17,360 FOR THAT. 410 00:14:17,360 --> 00:14:18,720 WE OBTAINED GUIDANCE FROM OUR 411 00:14:18,720 --> 00:14:21,000 OFFICE OF GENERAL COUNSEL 412 00:14:21,000 --> 00:14:22,600 BECAUSE WE WANTED TO PROVIDE THE 413 00:14:22,600 --> 00:14:23,360 WORKING GROUP WITH SOME 414 00:14:23,360 --> 00:14:24,480 GUARDRAILS, WHAT THEY CAN AND 415 00:14:24,480 --> 00:14:27,400 CAN'T DO. 416 00:14:27,400 --> 00:14:29,600 AND WHAT THE GUIDANCE WE GOT IS 417 00:14:29,600 --> 00:14:31,240 THAT THE FIVE REVIEW CRITERIA 418 00:14:31,240 --> 00:14:33,880 THAT CURRENTLY EXISTS, 419 00:14:33,880 --> 00:14:35,200 SIGNIFICANCE, INVESTIGATORS, 420 00:14:35,200 --> 00:14:36,040 INNOVATION, APPROACH AND 421 00:14:36,040 --> 00:14:38,240 ENVIRONMENT, ARE ALL DEFINED BY 422 00:14:38,240 --> 00:14:39,600 THE PUBLIC HEALTH SERVICE CODE 423 00:14:39,600 --> 00:14:44,240 OF FEDERAL REGULATIONS. 424 00:14:44,240 --> 00:14:46,560 BUT NIH, THE AGENCY, HAS 425 00:14:46,560 --> 00:14:47,760 DISCRETION ON HOW TO INTERPRET 426 00:14:47,760 --> 00:14:49,480 THEM AND HOW TO GROUP THEM. 427 00:14:49,480 --> 00:14:51,280 WE CAN'T CHANGE THE CRITERIA, 428 00:14:51,280 --> 00:14:53,120 BUT WE CAN GROUP THEM THE WAY WE 429 00:14:53,120 --> 00:14:54,960 WANT, AND WE CAN DECIDE TO SCORE 430 00:14:54,960 --> 00:14:56,920 THEM OR NOT SCORE THEM AND WE 431 00:14:56,920 --> 00:14:58,720 HAVE DISCRETION ON MATTERS OF 432 00:14:58,720 --> 00:15:01,880 SCORING. 433 00:15:01,880 --> 00:15:04,360 THIS IS JUST A SNAPSHOT OF THE 434 00:15:04,360 --> 00:15:05,280 WORKING GROUP, AND YOU CAN SEE 435 00:15:05,280 --> 00:15:06,600 HERE THAT WE HAVE MEMBERS FROM 436 00:15:06,600 --> 00:15:08,680 OUR ADVISORY COUNCIL, WE HAVE -- 437 00:15:08,680 --> 00:15:12,600 THIS WAS CO-LED BY TANYA POLERMO 438 00:15:12,600 --> 00:15:16,760 AND BRUCE REID FROM CENTER FROM 439 00:15:16,760 --> 00:15:18,960 SCIENTIFIC REVIEW, AND MEMBERS 440 00:15:18,960 --> 00:15:22,560 OF ADVISORY COUNCIL, AD HOC, 441 00:15:22,560 --> 00:15:23,880 SOME PARTICIPATED IN JUST THE 442 00:15:23,880 --> 00:15:25,320 NON-CLINICAL TRIALS, SOME IN 443 00:15:25,320 --> 00:15:26,600 CLINICAL TRIALS AND SOME IN BOTH 444 00:15:26,600 --> 00:15:29,960 GROUPS. 445 00:15:29,960 --> 00:15:32,160 SO THE PROCESS, WE STARTED OFF 446 00:15:32,160 --> 00:15:35,920 BY GETTING INPUT. 447 00:15:35,920 --> 00:15:41,480 WE PUT THIS OUT ON A REVIEW BLOG 448 00:15:41,480 --> 00:15:44,160 THAT HAS ABOUT A HUNDRED 449 00:15:44,160 --> 00:15:46,640 THOUSAND SUBSCRIBERS, IT WAS PUT 450 00:15:46,640 --> 00:15:49,200 ON OPEN MIC BLOG THAT HAS 451 00:15:49,200 --> 00:15:50,320 350,000 SUBSCRIBERS. 452 00:15:50,320 --> 00:15:53,080 THE CSR BLOG ALONE GOT MORE THAN 453 00:15:53,080 --> 00:15:55,600 9,000 PAGE VIEWS, WE GOT MORE 454 00:15:55,600 --> 00:15:57,480 THAN 400 COMMENTS. 455 00:15:57,480 --> 00:15:59,280 WE DID A CONTENT ANALYSIS AND WE 456 00:15:59,280 --> 00:16:00,400 PROVIDED THIS TO THE WORKING 457 00:16:00,400 --> 00:16:01,600 GROUPS, WHICH AS YOU WILL SEE, 458 00:16:01,600 --> 00:16:03,360 THEY REALLY TOOK -- THEY AGREED 459 00:16:03,360 --> 00:16:06,880 WITH MANY OF THE MAJOR THEMES 460 00:16:06,880 --> 00:16:10,040 THAT EMERGED AND THEIR 461 00:16:10,040 --> 00:16:10,800 RECOMMENDATIONS ARE SORT OF 462 00:16:10,800 --> 00:16:11,920 ALIGNED WITH WHAT WE HEARD. 463 00:16:11,920 --> 00:16:15,600 JUST BROADLY, THE MAIN THEMES OF 464 00:16:15,600 --> 00:16:17,600 THE CONTENT ANALYSIS WERE PEOPLE 465 00:16:17,600 --> 00:16:19,080 WERE CONFUSED ABOUT INNOVATION, 466 00:16:19,080 --> 00:16:20,320 THEY DIDN'T KNOW HOW TO ASSESS 467 00:16:20,320 --> 00:16:25,280 IT, WHETHER IT'S TECHNICAL, 468 00:16:25,280 --> 00:16:27,320 CONCEPTUAL, WHAT TO DO ABOUT 469 00:16:27,320 --> 00:16:28,520 INNOVATION OF REALLY IMPORTANT 470 00:16:28,520 --> 00:16:30,160 PROJECTS THAT ARE NOT REALLY 471 00:16:30,160 --> 00:16:32,680 THAT INNOVATIVE BUT IMPORTANT TO 472 00:16:32,680 --> 00:16:35,320 DO. 473 00:16:35,320 --> 00:16:36,320 INVESTIGATOR/ENVIRONMENT, WE 474 00:16:36,320 --> 00:16:37,840 TALKED ABOUT THAT. 475 00:16:37,840 --> 00:16:39,680 AND ADDITIONAL REVIEW 476 00:16:39,680 --> 00:16:41,320 CONSIDERATIONS, SUGGESTED TO 477 00:16:41,320 --> 00:16:44,400 MOVE TO ADMINISTRATIVE REVIEW, 478 00:16:44,400 --> 00:16:51,120 AND EMPHASIS ON FEASIBILITY AND 479 00:16:51,120 --> 00:16:51,720 RIGOR. 480 00:16:51,720 --> 00:16:53,960 SO THE EXTERNAL INPUT GATHERING 481 00:16:53,960 --> 00:16:55,560 AND THE PROCESS, IT WAS STARTED 482 00:16:55,560 --> 00:16:57,000 IN JANUARY, SEVEN VIRTUAL 483 00:16:57,000 --> 00:16:58,280 MEETINGS WERE HELD BY THE 484 00:16:58,280 --> 00:17:00,600 NON-CLINICAL TRIALS WORKING 485 00:17:00,600 --> 00:17:01,320 GROUP. 486 00:17:01,320 --> 00:17:03,000 AN INTERIM REPORT WAS PRESENTED 487 00:17:03,000 --> 00:17:04,400 AND IT WAS DISCUSSED BY THE FULL 488 00:17:04,400 --> 00:17:06,040 ADVISORY COUNCIL THAT WAS 489 00:17:06,040 --> 00:17:07,480 SUPPORTIVE AND HAD SOME 490 00:17:07,480 --> 00:17:07,920 SUGGESTIONS. 491 00:17:07,920 --> 00:17:09,680 WE TOOK A BREAK FOR THE 492 00:17:09,680 --> 00:17:11,520 PANDEMIC, JUST TO REGROUP AND 493 00:17:11,520 --> 00:17:13,600 CONTINUE TO HOLD PEER REVIEW 494 00:17:13,600 --> 00:17:15,160 MEETINGS, BUT THEN WE REGROUPED 495 00:17:15,160 --> 00:17:19,600 IN SEPTEMBER 2021 WHERE THE 496 00:17:19,600 --> 00:17:20,800 CLINICAL TRIALS WORKING GROUP 497 00:17:20,800 --> 00:17:21,920 HAD FOUR VIRTUAL MEETINGS AND 498 00:17:21,920 --> 00:17:23,360 THEN A COMBINED SET OF 499 00:17:23,360 --> 00:17:24,080 RECOMMENDATIONS WERE PRESENTED 500 00:17:24,080 --> 00:17:26,560 IN MARCH 2021, AND WERE APPROVED 501 00:17:26,560 --> 00:17:28,640 BY THE FULL CSR ADVISORY 502 00:17:28,640 --> 00:17:29,440 COUNCIL. 503 00:17:29,440 --> 00:17:31,640 THE FINAL REPORT OF THIS WAS 504 00:17:31,640 --> 00:17:35,800 POSTED ON OUR WEBSITE. 505 00:17:35,800 --> 00:17:37,520 AT THAT POINT, THE PROCESS MOVED 506 00:17:37,520 --> 00:17:39,200 INTERNAL TO NIH, SO WE TOOK 507 00:17:39,200 --> 00:17:43,320 THOSE RECOMMENDATIONS TO A 508 00:17:43,320 --> 00:17:44,680 TRANS-NIH EXTRAMURAL ACTIVITIES 509 00:17:44,680 --> 00:17:45,760 WORKING GROUP THAT'S ADVISORY TO 510 00:17:45,760 --> 00:17:47,840 THE STEERING COMMITTEE OF NIH, 511 00:17:47,840 --> 00:17:49,920 WHICH FORMED A COMMITTEE TO SORT 512 00:17:49,920 --> 00:17:51,600 OF LOOK THROUGH DEEPLY AT ALL OF 513 00:17:51,600 --> 00:17:54,840 THE RECOMMENDATIONS AND DEVELOP 514 00:17:54,840 --> 00:17:56,480 AND MODIFY THOSE TO BE PRACTICAL 515 00:17:56,480 --> 00:17:58,880 AND TO ADDRESS THE ISSUES THAT 516 00:17:58,880 --> 00:18:00,520 WE THOUGHT NEEDED TO BE 517 00:18:00,520 --> 00:18:01,480 ADDRESSED. 518 00:18:01,480 --> 00:18:04,120 I HAVE PROVIDED A COUPLE OF 519 00:18:04,120 --> 00:18:05,720 UPDATES, STATUS UPDATES AT 520 00:18:05,720 --> 00:18:08,480 PUBLIC ADVISORY COUNCIL 521 00:18:08,480 --> 00:18:09,920 MEETINGS, AS WE'VE GONE ALONG 522 00:18:09,920 --> 00:18:11,560 BECAUSE OUR ADVISORY COUNCIL IS 523 00:18:11,560 --> 00:18:13,840 VERY INVESTED IN THIS AND WANTS 524 00:18:13,840 --> 00:18:15,120 TO KNOW, BUT WE HAVEN'T 525 00:18:15,120 --> 00:18:15,880 ACTUALLY -- THIS IS THE FIRST 526 00:18:15,880 --> 00:18:17,960 TIME WE'RE GOING TO BE 527 00:18:17,960 --> 00:18:20,120 PRESENTING THE NIH MODIFICATIONS 528 00:18:20,120 --> 00:18:21,760 TO WHAT WAS PROPOSED BY THE 529 00:18:21,760 --> 00:18:23,480 ADVISORY COUNCIL. 530 00:18:23,480 --> 00:18:26,800 SO NIH IN APRIL 2022 PROPOSED 531 00:18:26,800 --> 00:18:27,880 SOME MODIFICATIONS. 532 00:18:27,880 --> 00:18:29,520 THOSE WERE PRESENTED INTERNALLY 533 00:18:29,520 --> 00:18:32,600 TO NIH LEADERSHIP, AND THEY 534 00:18:32,600 --> 00:18:34,200 APPROVED THE THREE-FACTOR 535 00:18:34,200 --> 00:18:35,080 FRAMEWORK THAT I'M GOING TO TALK 536 00:18:35,080 --> 00:18:41,200 TO YOU ABOUT. 537 00:18:41,200 --> 00:18:42,880 SO THE MAJOR RECOMMENDATIONS OF 538 00:18:42,880 --> 00:18:44,520 THE EXTERNAL ADVISORY GROUP FOR 539 00:18:44,520 --> 00:18:46,600 THE NEW PEER REVIEW FRAMEWORK 540 00:18:46,600 --> 00:18:48,680 WERE THIS: FIRST, REORGANIZE 541 00:18:48,680 --> 00:18:50,720 THE CURRENT FIVE SCORED REVIEW 542 00:18:50,720 --> 00:18:53,360 CRITERIA INTO THREE FACTORS THAT 543 00:18:53,360 --> 00:18:54,600 ADDRESS THE THREE QUESTIONS: 544 00:18:54,600 --> 00:18:56,280 SHOULD IT BE DONE, CAN IT BE 545 00:18:56,280 --> 00:18:57,680 DONE, WILL IT BE DONE? 546 00:18:57,680 --> 00:18:59,480 SO FACTOR ONE WAS IMPORTANCE OF 547 00:18:59,480 --> 00:19:01,680 THE RESEARCH UNDER THAT FALL THE 548 00:19:01,680 --> 00:19:04,520 TWO REQUIRED CRITERIA, 549 00:19:04,520 --> 00:19:05,800 SIGNIFICANCE, INNOVATION. 550 00:19:05,800 --> 00:19:07,000 FACTOR TWO WAS FEASIBILITY AND 551 00:19:07,000 --> 00:19:08,040 RIGOR, WHICH IS APPROACH. 552 00:19:08,040 --> 00:19:10,840 AND THEN FACTOR THREE WAS 553 00:19:10,840 --> 00:19:12,640 INVESTIGATOR AND ENVIRONMENT. 554 00:19:12,640 --> 00:19:15,520 THEY ALSO RECOMMENDED THAT MOST 555 00:19:15,520 --> 00:19:17,520 ADDITIONAL REVIEW CRITERIA, 556 00:19:17,520 --> 00:19:19,920 THESE ARE LIKE HUMAN SUBJECTS, 557 00:19:19,920 --> 00:19:21,120 VERTEBRATE ANIMALS THAT HAVE AN 558 00:19:21,120 --> 00:19:23,560 IMPACT ON THE SCORE, REMAIN 559 00:19:23,560 --> 00:19:23,840 UNCHANGED. 560 00:19:23,840 --> 00:19:26,600 THEY DID SUGGEST THAT MOST 561 00:19:26,600 --> 00:19:28,040 REVIEW CONSIDERATIONS, THESE ARE 562 00:19:28,040 --> 00:19:31,840 THINGS THAT DO NOT AFFECT SCORE, 563 00:19:31,840 --> 00:19:32,520 BUT PEER REVIEW HAS BEEN ASKED 564 00:19:32,520 --> 00:19:34,680 TO WEIGH IN ON, THEY DID SUGGEST 565 00:19:34,680 --> 00:19:36,560 THAT THOSE BE REMOVED FROM THE 566 00:19:36,560 --> 00:19:38,080 FIRST LEVEL OF PEER REVIEW. 567 00:19:38,080 --> 00:19:41,360 THERE IS A DETAILED REPORT, 568 00:19:41,360 --> 00:19:43,120 WHICH HAS BEEN PROVIDED TO YOU, 569 00:19:43,120 --> 00:19:48,560 I THINK, AND HAS ALL OF THE 570 00:19:48,560 --> 00:19:51,520 DETAILED RECOMMENDATIONS. 571 00:19:51,520 --> 00:19:54,160 SO FOR NIH, THIS HAPPENED 572 00:19:54,160 --> 00:19:56,960 AROUND, I DON'T KNOW, SUMMER OF 573 00:19:56,960 --> 00:19:57,960 2020 AND BEYOND THAT, AND WE 574 00:19:57,960 --> 00:20:00,320 WERE GETTING A LOT OF FEEDBACK 575 00:20:00,320 --> 00:20:03,040 ABOUT HOW BIAS COMES INTO THE 576 00:20:03,040 --> 00:20:07,280 REVIEW PROCESS AND HOW TIGHTLY 577 00:20:07,280 --> 00:20:08,280 IT'S LINKED TO RACIAL 578 00:20:08,280 --> 00:20:09,040 DISPARITIES AND OTHERS. 579 00:20:09,040 --> 00:20:13,000 AND WE WERE LOOKING CAREFULLY AT 580 00:20:13,000 --> 00:20:14,280 WHERE BIAS COMES IN TO THE 581 00:20:14,280 --> 00:20:14,640 REVIEW PROCESS. 582 00:20:14,640 --> 00:20:15,800 THIS WAS AN OPPORTUNITY FOR US, 583 00:20:15,800 --> 00:20:17,880 AS WE WERE RESTRUCTURING REVIEW 584 00:20:17,880 --> 00:20:19,520 CRITERIA, TO THINK ABOUT THAT. 585 00:20:19,520 --> 00:20:22,160 THE OTHER THING WE WERE 586 00:20:22,160 --> 00:20:23,680 THINKING -- THAT AS PART OF 587 00:20:23,680 --> 00:20:26,000 DEVELOPING BIAS TRAINING, WE 588 00:20:26,000 --> 00:20:28,600 LOOKED AT LITERATURE IN 589 00:20:28,600 --> 00:20:29,520 EVALUATIONS FROM MULTIPLE 590 00:20:29,520 --> 00:20:30,920 DIFFERENT FIELDS, AND ONE THING 591 00:20:30,920 --> 00:20:32,520 THAT'S CLEAR FROM ALL FIELDS IS 592 00:20:32,520 --> 00:20:36,960 THAT THE MORE SPECIFIC YOU MAKE 593 00:20:36,960 --> 00:20:38,760 THE REVIEW CRITERIA AND THE MORE 594 00:20:38,760 --> 00:20:40,400 YOU MAKE THE EVALUATORS BE 595 00:20:40,400 --> 00:20:42,040 SPECIFIC, THE LESS BIAS YOU'LL 596 00:20:42,040 --> 00:20:48,280 HAVE IN THE EVALUATION. 597 00:20:48,280 --> 00:20:50,040 AND FOR RPGs, WHICH ARE 598 00:20:50,040 --> 00:20:50,960 RESEARCH PROJECT GRANTS, WHAT 599 00:20:50,960 --> 00:20:53,120 WE'RE TRYING TO DO IS HAVE 600 00:20:53,120 --> 00:20:55,520 INVESTIGATOR AND ENVIRONMENT 601 00:20:55,520 --> 00:20:56,640 EVALUATED IN THE CONTEXT OF THE 602 00:20:56,640 --> 00:20:57,160 PROJECT, RIGHT? 603 00:20:57,160 --> 00:20:59,240 THIS IS NOT ABOUT THE 604 00:20:59,240 --> 00:21:01,200 INVESTIGATOR'S PEDIGREE OR 605 00:21:01,200 --> 00:21:02,080 RECOGNITION FACTOR OR 606 00:21:02,080 --> 00:21:02,400 REPUTATION. 607 00:21:02,400 --> 00:21:04,280 THIS IS ENTIRELY RELATED TO THE 608 00:21:04,280 --> 00:21:04,840 PROJECT. 609 00:21:04,840 --> 00:21:06,120 DOES THE INVESTIGATOR HAVE THE 610 00:21:06,120 --> 00:21:08,120 TRAINING AND EXPERTISE TO DO THE 611 00:21:08,120 --> 00:21:08,600 PROJECT? 612 00:21:08,600 --> 00:21:10,520 SAME WITH RESOURCES FOR THE 613 00:21:10,520 --> 00:21:10,960 ENVIRONMENT. 614 00:21:10,960 --> 00:21:13,240 IT'S NOT ABOUT THE PRESTIGE OF 615 00:21:13,240 --> 00:21:15,400 THE INSTITUTION, BUT RATHER THE 616 00:21:15,400 --> 00:21:16,600 RESOURCES PRESENT TO COMPLETE 617 00:21:16,600 --> 00:21:17,960 THE PROJECT. 618 00:21:17,960 --> 00:21:19,880 BUT THE WAY THE REVIEW CRITERIA 619 00:21:19,880 --> 00:21:23,920 ARE STRUCTURED RIGHT NOW, WHICH 620 00:21:23,920 --> 00:21:25,600 IS -- THERE'S A SCORE FROM 1 TO 621 00:21:25,600 --> 00:21:29,760 9 FOR INVESTIGATOR, ENVIRONMENT, 622 00:21:29,760 --> 00:21:32,280 YOU CAN WRITE BULLETED STRENGTHS 623 00:21:32,280 --> 00:21:33,920 AND WEAKNESSES BUT IT'S 624 00:21:33,920 --> 00:21:35,120 BASICALLY OPEN-ENDED NARRATIVE. 625 00:21:35,120 --> 00:21:36,960 THAT GIVES REVIEWERS LATITUDE, 626 00:21:36,960 --> 00:21:37,160 RIGHT? 627 00:21:37,160 --> 00:21:39,040 IF IT'S NOT SPECIFIC, IT DOESN'T 628 00:21:39,040 --> 00:21:40,360 FORCE PEOPLE INTO REALLY NAILING 629 00:21:40,360 --> 00:21:41,280 DOWN THE SPECIFICS OF WHAT 630 00:21:41,280 --> 00:21:41,920 CONCERNS THERE ARE. 631 00:21:41,920 --> 00:21:44,160 SO WE END UP SEEING THINGS LIKE, 632 00:21:44,160 --> 00:21:47,240 YOU KNOW, FAINT PRAISE FOR AN 633 00:21:47,240 --> 00:21:48,800 INSTITUTION THAT'S NOT WELL 634 00:21:48,800 --> 00:21:50,400 RECOGNIZED OR NOT WELL 635 00:21:50,400 --> 00:21:50,880 RESOURCED. 636 00:21:50,880 --> 00:21:54,000 IT'S FINE FOR AN HBCU, BUT FOR 637 00:21:54,000 --> 00:21:55,360 HARVARD, IT'S THE BEST THING 638 00:21:55,360 --> 00:21:55,680 EVER. 639 00:21:55,680 --> 00:22:00,200 YOU KNOW, OR DR. X IS A LEADER 640 00:22:00,200 --> 00:22:02,560 IN THE FIELD AND HAS MADE 641 00:22:02,560 --> 00:22:03,320 SEVERAL CONTRIBUTIONS. 642 00:22:03,320 --> 00:22:05,200 AND DR. Y SEEMS TO HAVE THE 643 00:22:05,200 --> 00:22:07,520 EXPERTISE AND A SCORE OF A 644 00:22:07,520 --> 00:22:08,800 4 WITHOUT MUCH EXPLANATION AS TO 645 00:22:08,800 --> 00:22:14,280 WHY THAT'S A 4. 646 00:22:14,280 --> 00:22:16,160 SO THE NEW REVIEW FRAMEWORK AND 647 00:22:16,160 --> 00:22:17,880 THE NIH PROPOSED MODIFICATIONS 648 00:22:17,880 --> 00:22:23,120 TO WHAT THE ADVISORY COUNCIL 649 00:22:23,120 --> 00:22:24,800 PROPOSED, CENTER MOSTLY AROUND 650 00:22:24,800 --> 00:22:25,320 FACTOR THREE. 651 00:22:25,320 --> 00:22:27,400 THERE ARE SOME, YOU KNOW, 652 00:22:27,400 --> 00:22:31,240 CHANGES TO WORDING AND SUCH IN 653 00:22:31,240 --> 00:22:32,520 FACTORS ONE AND TWO, BUT THE 654 00:22:32,520 --> 00:22:35,800 MAJOR CHANGE IS TO FACTOR THREE. 655 00:22:35,800 --> 00:22:38,120 WHICH NIH HAS PROPOSED BE 656 00:22:38,120 --> 00:22:40,080 RENAMED EXPERTISE AND RESOURCES, 657 00:22:40,080 --> 00:22:42,160 UNDER WHICH FALL INVESTIGATOR 658 00:22:42,160 --> 00:22:45,320 AND ENVIRONMENT, AND THAT FACTOR 659 00:22:45,320 --> 00:22:47,000 ITSELF NOT RECEIVE A SCORE, BUT 660 00:22:47,000 --> 00:22:48,640 IT DOES COUNT TOWARD THE OVERALL 661 00:22:48,640 --> 00:22:50,720 IMPACT SCORE. 662 00:22:50,720 --> 00:22:53,840 IT BEEN CHANGED TO -- WE'RE 663 00:22:53,840 --> 00:22:55,280 PROPOSING A CHANGE TO A 664 00:22:55,280 --> 00:22:55,760 DROPDOWN. 665 00:22:55,760 --> 00:22:57,920 WHAT THAT MEANS IS, DOES THE 666 00:22:57,920 --> 00:22:59,120 INVESTIGATOR HAVE THE EXPERTISE 667 00:22:59,120 --> 00:23:00,840 AND TRAINING, IF YOU THINK 668 00:23:00,840 --> 00:23:03,400 THAT'S APPROPRIATE FOR THE 669 00:23:03,400 --> 00:23:03,720 PROJECT. 670 00:23:03,720 --> 00:23:06,560 APPROPRIATE, YOU DON'T HAVE TO 671 00:23:06,560 --> 00:23:07,240 WRITE ANYTHING. 672 00:23:07,240 --> 00:23:09,080 IF YOU DON'T THINK -- IF THERE'S 673 00:23:09,080 --> 00:23:10,480 SOME GAPS WHICH SHOULD BE 674 00:23:10,480 --> 00:23:12,040 IDENTIFIED, THEN THOSE NEED TO 675 00:23:12,040 --> 00:23:13,560 BE EXPLICITLY MENTIONED, IT 676 00:23:13,560 --> 00:23:14,560 SHOULD AFFECT THE OVERALL IMPACT 677 00:23:14,560 --> 00:23:14,880 SCORE. 678 00:23:14,880 --> 00:23:18,120 SO THIS IS A PRETTY MAJOR CHANGE 679 00:23:18,120 --> 00:23:19,360 TO FACTOR THREE, AND THERE ARE 680 00:23:19,360 --> 00:23:20,760 SOME OTHER CHANGES TO THE 681 00:23:20,760 --> 00:23:21,960 ADDITIONAL REVIEW CRITERIA AS 682 00:23:21,960 --> 00:23:28,080 WELL. 683 00:23:28,080 --> 00:23:30,800 SO THE NEXT STEPS ARE -- WE HAVE 684 00:23:30,800 --> 00:23:32,400 A COUPLE OF ONGOING EFFORTS THAT 685 00:23:32,400 --> 00:23:34,880 ARE WINDING DOWN, WHICH IS WE 686 00:23:34,880 --> 00:23:36,400 HAVE A TRANS-NIH COMMITTEE 687 00:23:36,400 --> 00:23:39,240 THAT'S LOOKING AT INCORPORATING 688 00:23:39,240 --> 00:23:40,240 RIGOROUS REVIEW OF CLINICAL 689 00:23:40,240 --> 00:23:42,000 TRIALS INTO THE PROPOSED 690 00:23:42,000 --> 00:23:42,960 FRAMEWORK. 691 00:23:42,960 --> 00:23:44,520 SO CLINICAL TRIAL RPGs INTO 692 00:23:44,520 --> 00:23:45,400 THE PROPOSED FRAMEWORK. 693 00:23:45,400 --> 00:23:47,920 AND THEN THE BRAIN INITIATIVE 694 00:23:47,920 --> 00:23:51,080 HAS A PLAN TO ENHANCE DIVERSE 695 00:23:51,080 --> 00:23:52,280 PERSPECTIVES THAT THEY'RE USING 696 00:23:52,280 --> 00:23:54,440 IN ALL OF THEIR INITIATIVES, AND 697 00:23:54,440 --> 00:23:55,760 WE'RE TRYING TO SEE HOW WE CAN 698 00:23:55,760 --> 00:23:56,560 INCORPORATE THAT INTO SORT OF 699 00:23:56,560 --> 00:23:59,720 THE BROADER RPG FRAMEWORK. 700 00:23:59,720 --> 00:24:02,320 SO THE NEXT STEPS ARE PUBLIC -- 701 00:24:02,320 --> 00:24:03,880 OR THIS IS STEP ONE OF THE 702 00:24:03,880 --> 00:24:08,440 PUBLIC ROLLOUT, SO THE CHANGE TO 703 00:24:08,440 --> 00:24:10,840 FACTOR THREE AND NIH PUSH 704 00:24:10,840 --> 00:24:11,640 MODIFICATIONS HAVEN'T YET 705 00:24:11,640 --> 00:24:13,840 PUBLICLY BEEN DISCUSSED SO ACD 706 00:24:13,840 --> 00:24:14,600 IS THE FIRST TIME WE'RE 707 00:24:14,600 --> 00:24:15,480 DISCUSSING WITH THE PUBLIC AND 708 00:24:15,480 --> 00:24:16,760 WOULD LIKE TO HEAR YOUR INPUT. 709 00:24:16,760 --> 00:24:21,120 WE ARE GOING TO ISSUE AN RFI IN 710 00:24:21,120 --> 00:24:22,400 THE NOVEMBER/DECEMBER TIME FRAME 711 00:24:22,400 --> 00:24:25,200 AND THEN WE EXPECT TO HAVE A 712 00:24:25,200 --> 00:24:27,760 FULLER DISCUSSION AT THE 713 00:24:27,760 --> 00:24:28,720 DECEMBER ACD. 714 00:24:28,720 --> 00:24:30,440 AND JUST FOR YOUR AWARENESS, WE 715 00:24:30,440 --> 00:24:32,920 JUST COMPLETED A CSR ADVISORY 716 00:24:32,920 --> 00:24:34,600 COUNCIL WORKING GROUP THAT WAS 717 00:24:34,600 --> 00:24:36,680 LOOKING AT NRSA FELLOWSHIP 718 00:24:36,680 --> 00:24:38,760 REVIEW CRITERIA, AND THEY HAVE 719 00:24:38,760 --> 00:24:40,280 ISSUED SOME RECOMMENDATIONS THAT 720 00:24:40,280 --> 00:24:41,720 ARE AVAILABLE THAT THOSE ARE 721 00:24:41,720 --> 00:24:43,360 UNDER CONSIDERATION BY THE NIH 722 00:24:43,360 --> 00:24:49,880 RIGHT NOW. 723 00:24:49,880 --> 00:24:51,040 SO I'LL STOP SHARING. 724 00:24:51,040 --> 00:24:52,120 HAPPY TO TAKE QUESTIONS. 725 00:24:52,120 --> 00:24:54,880 >>THANKS, NONI. 726 00:24:54,880 --> 00:24:56,280 IF FOLKS HAVE QUESTIONS, PLEASE 727 00:24:56,280 --> 00:24:58,880 RAISE YOUR HAND AND WE'LL -- WE 728 00:24:58,880 --> 00:25:00,320 HAVE TIME FOR A COUPLE. 729 00:25:00,320 --> 00:25:01,400 REMEMBER, THIS IS GOING TO BE 730 00:25:01,400 --> 00:25:03,600 PRESENTED IN MORE DETAIL IN 731 00:25:03,600 --> 00:25:04,920 DECEMBER, AND THERE WILL BE 732 00:25:04,920 --> 00:25:08,800 AMPLE TIME FOR DISCUSSION THEN. 733 00:25:08,800 --> 00:25:10,040 IF THERE ARE SOME QUESTIONS, 734 00:25:10,040 --> 00:25:11,440 HAPPY TO HAVE A BIT OF A 735 00:25:11,440 --> 00:25:14,280 CONVERSATION. 736 00:25:14,280 --> 00:25:16,360 I DO SEE SOME CAMERAS THAT HAVE 737 00:25:16,360 --> 00:25:18,560 TURNED ON BUT I DON'T SEE ANY 738 00:25:18,560 --> 00:25:25,040 HANDS RAISED JUST YET. 739 00:25:25,040 --> 00:25:26,160 ROBI, YOU HAVE YOUR HAND UP? 740 00:25:26,160 --> 00:25:27,880 >>THE QUESTION I HAVE ARE WHAT 741 00:25:27,880 --> 00:25:30,520 ARE THE METRICS OF SUCCESS FOR 742 00:25:30,520 --> 00:25:33,960 THIS ASSESSMENT AND POTENTIAL 743 00:25:33,960 --> 00:25:42,000 CHANGE IN PEER REVIEW? 744 00:25:42,000 --> 00:25:43,360 >>SO THAT'S A GOOD QUESTION, 745 00:25:43,360 --> 00:25:45,240 AND IT'S A QUESTION FOR EVERY 746 00:25:45,240 --> 00:25:48,440 INITIATIVE THAT WE UNDERTAKE. 747 00:25:48,440 --> 00:25:50,880 I THINK THE ULTIMATE OUTCOMES OF 748 00:25:50,880 --> 00:25:52,480 PEER REVIEW IS WHO GETS THROUGH 749 00:25:52,480 --> 00:25:53,680 PEER REVIEW, WHAT KINDS OF 750 00:25:53,680 --> 00:25:58,200 SCORING OCCURS FOR THAT FACTOR 751 00:25:58,200 --> 00:25:59,680 THREE FOR INVESTIGATORS. 752 00:25:59,680 --> 00:26:00,680 BECAUSE CURRENTLY WE HAVE -- WE 753 00:26:00,680 --> 00:26:04,080 HAVE SOME DATA ON INVESTIGATOR 754 00:26:04,080 --> 00:26:07,360 AND ENVIRONMENT SCORING, AND 755 00:26:07,360 --> 00:26:08,960 WHEN THERE'S DISCREPANCIES THAT 756 00:26:08,960 --> 00:26:11,080 AREN'T FULLY EXPLAINED. 757 00:26:11,080 --> 00:26:15,240 SO I THINK IT WOULD BE MORE 758 00:26:15,240 --> 00:26:19,080 ANALYSIS OF THE CRITERIA, AND 759 00:26:19,080 --> 00:26:20,720 WHAT BASIS PEOPLE ARE ASSESSING 760 00:26:20,720 --> 00:26:22,040 THOSE ON. 761 00:26:22,040 --> 00:26:23,880 I THINK REMOVING THE SCORE FROM 762 00:26:23,880 --> 00:26:25,800 THE CRITERIA, REMEMBER, 10, 15 763 00:26:25,800 --> 00:26:27,280 YEARS AGO, THERE WAS NO SCORE 764 00:26:27,280 --> 00:26:28,360 FOR ANY CRITERIA. 765 00:26:28,360 --> 00:26:30,120 THEN WE ADDED CRITERIA SCORES 766 00:26:30,120 --> 00:26:31,680 FOR INVESTIGATOR AND 767 00:26:31,680 --> 00:26:32,080 ENVIRONMENT. 768 00:26:32,080 --> 00:26:35,920 AND THAT'S BECOME A BIT 769 00:26:35,920 --> 00:26:36,720 PROBLEMATIC, BECAUSE -- AND 770 00:26:36,720 --> 00:26:37,920 THAT'S OUR DATA FROM JUST 771 00:26:37,920 --> 00:26:39,560 LOOKING AT SCORING AND WHICH 772 00:26:39,560 --> 00:26:40,120 INSTITUTIONS IT COMES FROM. 773 00:26:40,120 --> 00:26:41,840 SO I THINK ULTIMATELY IT'S 774 00:26:41,840 --> 00:26:43,240 OUTCOMES OF PEER REVIEW, YOU 775 00:26:43,240 --> 00:26:46,160 KNOW, WHO'S BEING SUCCESSFUL 776 00:26:46,160 --> 00:26:47,240 COMING OUT OF PEER REVIEW AND 777 00:26:47,240 --> 00:26:49,040 HOW MUCH THAT'S RELATED TO WHERE 778 00:26:49,040 --> 00:26:50,400 THEY'RE COMING FROM. 779 00:26:50,400 --> 00:26:54,200 ONE OF THE CONCERNS WE HEARD WAS 780 00:26:54,200 --> 00:26:55,280 UNDERRESOURCED -- ACTUALLY NOT 781 00:26:55,280 --> 00:26:56,840 EVEN UNDERRESOURCED, BUT MIDDLE 782 00:26:56,840 --> 00:26:59,640 OF THE COUNTRY INSTITUTIONS, 783 00:26:59,640 --> 00:27:03,160 WHERE THE SAME INDIVIDUAL MIGHT 784 00:27:03,160 --> 00:27:06,480 BE -- WAS AT ONE OF THE IVIES ON 785 00:27:06,480 --> 00:27:07,680 THE EAST COAST, MOVED TO THE 786 00:27:07,680 --> 00:27:09,600 MIDDLE OF THE COUNTRY AND HIS 787 00:27:09,600 --> 00:27:12,680 INVESTIGATOR SCORE WENT DOWN, 788 00:27:12,680 --> 00:27:14,320 HIS INSTITUTIONAL WENT SCORE AND 789 00:27:14,320 --> 00:27:15,840 HIS OVERALL IMPACT SCORE WENT 790 00:27:15,840 --> 00:27:16,320 DOWN. 791 00:27:16,320 --> 00:27:17,440 PRETTY MUCH THE SAME RESEARCH. 792 00:27:17,440 --> 00:27:19,240 SO I THINK WE HAVE TO LOOK AT 793 00:27:19,240 --> 00:27:21,440 OUTCOMES IN A MORE SYSTEMATIC 794 00:27:21,440 --> 00:27:29,560 WAY. 795 00:27:29,560 --> 00:27:33,680 >>ANY OTHER QUESTIONS? 796 00:27:33,680 --> 00:27:36,680 GARTH, I SEE YOU RAISED YOUR 797 00:27:36,680 --> 00:27:38,280 ACTUAL HAND FIRST AND ATUL, YOU 798 00:27:38,280 --> 00:27:43,760 HAVE YOUR HAND UP. 799 00:27:43,760 --> 00:27:44,960 GARTH, DID YOU WANT TO ASK YOUR 800 00:27:44,960 --> 00:27:46,520 QUESTION? 801 00:27:46,520 --> 00:27:51,440 WE CAN'T HEAR YOU. 802 00:27:51,440 --> 00:27:53,880 OKAY, WE'LL GO TO ATUL FIRST AND 803 00:27:53,880 --> 00:27:55,600 MAYBE BY THAT TIME, WE GET 804 00:27:55,600 --> 00:27:57,120 THROUGH WITH THAT, THEN YOUR 805 00:27:57,120 --> 00:27:59,200 AUDIO WILL BE FIGURED OUT. 806 00:27:59,200 --> 00:27:59,400 ATUL? 807 00:27:59,400 --> 00:28:00,920 >>SO OBVIOUSLY I CAN IMAGINE 808 00:28:00,920 --> 00:28:02,320 WHERE MOST OF THE RFI COMMENTS 809 00:28:02,320 --> 00:28:04,240 WILL BE COMING FROM, BUT WHAT'S 810 00:28:04,240 --> 00:28:05,640 THE PROCESS GOING TO HAPPEN FOR 811 00:28:05,640 --> 00:28:10,120 K AWARDS, FOR SBIRs, SO THOSE 812 00:28:10,120 --> 00:28:12,680 WOULD HAPPEN AFTER RPGs ARE 813 00:28:12,680 --> 00:28:12,880 SETTLED? 814 00:28:12,880 --> 00:28:14,720 WHAT WOULD HAPPEN NEXT? 815 00:28:14,720 --> 00:28:15,280 >>THANK YOU. 816 00:28:15,280 --> 00:28:16,720 THANKS FOR THAT QUESTION. 817 00:28:16,720 --> 00:28:19,880 WE'RE FOCUSED RIGHT NOW ON 818 00:28:19,880 --> 00:28:20,320 RPGs. 819 00:28:20,320 --> 00:28:22,520 WE'LL SEE WHAT COMES FROM THE 820 00:28:22,520 --> 00:28:24,360 RFI, SEE IF WE NEED TO MAKE ANY 821 00:28:24,360 --> 00:28:24,960 MODIFICATIONS. 822 00:28:24,960 --> 00:28:30,400 AND THEN GO TO THE NEXT STEP. 823 00:28:30,400 --> 00:28:32,360 AND I THINK THE K AWARDS ARE 824 00:28:32,360 --> 00:28:33,640 ACTUALLY MORE LINKED TO 825 00:28:33,640 --> 00:28:34,760 FELLOWSHIP AND WHAT WE LEARN 826 00:28:34,760 --> 00:28:41,760 FROM THE FELLOWSHIP PROCESS 827 00:28:41,760 --> 00:28:43,480 THAT'S -- AND COMING UP NEXT. 828 00:28:43,480 --> 00:28:45,320 >>GARTH, DO WE WANT TO TRY TO 829 00:28:45,320 --> 00:28:46,880 GO BACK? 830 00:28:46,880 --> 00:28:48,120 OKAY, WE STILL -- I STILL CAN'T 831 00:28:48,120 --> 00:28:53,920 HEAR YOU. 832 00:28:53,920 --> 00:28:55,160 WELL, WE'LL DEFINITELY HAVE TIME 833 00:28:55,160 --> 00:28:56,760 TO ASK YOUR QUESTION IN 834 00:28:56,760 --> 00:28:58,160 DECEMBER, SO IF YOU CAN DO THAT. 835 00:28:58,160 --> 00:28:59,560 OR IF YOU CAN PUT IT IN THE 836 00:28:59,560 --> 00:29:03,400 CHAT, WE CAN SEE ABOUT GETTING 837 00:29:03,400 --> 00:29:07,560 THAT ADDRESSED. 838 00:29:07,560 --> 00:29:10,960 WELL, IF THERE ARE NO MORE 839 00:29:10,960 --> 00:29:13,920 QUESTIONS, WE WILL MOVE ON. 840 00:29:13,920 --> 00:29:15,680 WE ARE MAYBE 30 SECONDS AHEAD OF 841 00:29:15,680 --> 00:29:17,960 SCHEDULE HERE. 842 00:29:17,960 --> 00:29:21,680 SO IMPRESSIVE. 843 00:29:21,680 --> 00:29:23,120 SO SHIFTING TO THE NEXT ITEM, 844 00:29:23,120 --> 00:29:24,840 AND THANK YOU SO MUCH, NONI, FOR 845 00:29:24,840 --> 00:29:26,280 THAT PRESENTATION, AND LOOK 846 00:29:26,280 --> 00:29:29,480 FORWARD TO MORE DISCUSSION IN 847 00:29:29,480 --> 00:29:30,120 DECEMBER. 848 00:29:30,120 --> 00:29:32,720 MOVING ON TO THE NEXT TOPIC, WE 849 00:29:32,720 --> 00:29:34,960 ARE GOING TO DISCUSS A PROPOSED 850 00:29:34,960 --> 00:29:39,280 ACD WORKING GROUP THAT SHELLEY 851 00:29:39,280 --> 00:29:41,120 AND I ARE GOING TO BE DESCRIBING 852 00:29:41,120 --> 00:29:42,880 A LITTLE BIT MORE TO YOU ALL 853 00:29:42,880 --> 00:29:44,640 HERE SHORTLY. 854 00:29:44,640 --> 00:29:46,840 AND SO I'M GOING TO START THE 855 00:29:46,840 --> 00:29:47,680 PRESENTATION, AND THEN I'M GOING 856 00:29:47,680 --> 00:29:49,680 TO TURN IT OVER TO SHELLEY HERE 857 00:29:49,680 --> 00:29:51,520 IN A FEW MINUTES. 858 00:29:51,520 --> 00:29:52,840 BUT WE'RE GOING TO SHARE WITH 859 00:29:52,840 --> 00:29:55,480 YOU SOME REALLY PRELIMINARY 860 00:29:55,480 --> 00:29:58,880 THOUGHTS ON ESTABLISHING AN ACD 861 00:29:58,880 --> 00:30:00,800 WORKING GROUP THAT WILL ADDRESS 862 00:30:00,800 --> 00:30:01,560 NIH SUPPORTED POSTDOCTORAL 863 00:30:01,560 --> 00:30:02,920 TRAINING AND SOME OF THE 864 00:30:02,920 --> 00:30:08,440 CHALLENGES RELATED TO THIS TOPIC 865 00:30:08,440 --> 00:30:10,200 IN THE BIOMEDICAL ECOSYSTEM. 866 00:30:10,200 --> 00:30:12,200 SO IF WE COULD GO TO THE NEXT 867 00:30:12,200 --> 00:30:12,640 SLIDE. 868 00:30:12,640 --> 00:30:14,400 IN PARTICULAR, THERE ARE 869 00:30:14,400 --> 00:30:16,360 CONCERNS ABOUT A DECLINE, 870 00:30:16,360 --> 00:30:17,320 SOMETIMES I HEAR PEOPLE TALK 871 00:30:17,320 --> 00:30:19,280 ABOUT IT AS A SHORTAGE OF 872 00:30:19,280 --> 00:30:21,400 POSTDOCS. 873 00:30:21,400 --> 00:30:23,280 BUT THIS CHALLENGE SEEMS TO HAVE 874 00:30:23,280 --> 00:30:24,560 BEEN BREWING FOR A LITTLE BIT OF 875 00:30:24,560 --> 00:30:27,200 TIME, AND WHAT WE HAVE SEEN IS 876 00:30:27,200 --> 00:30:28,520 PUBLICATIONS GOING BACK 10 OR SO 877 00:30:28,520 --> 00:30:29,800 YEARS THAT INDICATE THAT THERE 878 00:30:29,800 --> 00:30:31,560 ARE CHALLENGES WITH THE 879 00:30:31,560 --> 00:30:33,880 POSTDOCTORAL TRAINEE PROCESS AND 880 00:30:33,880 --> 00:30:36,600 THE NUMBER OF POSTDOCS THAT ARE 881 00:30:36,600 --> 00:30:38,920 ENTERING INTO THAT CAREER ROUTE. 882 00:30:38,920 --> 00:30:41,400 SO THIS ISSUE ISN'T NEW. 883 00:30:41,400 --> 00:30:42,800 BUT IT'S SOMETHING THAT SEEMS TO 884 00:30:42,800 --> 00:30:44,560 BE BUBBLING UP A LOT LATELY, AND 885 00:30:44,560 --> 00:30:45,800 IN FACT, I JUST HEARD THIS THE 886 00:30:45,800 --> 00:30:47,880 OTHER DAY FROM A COUPLE OF 887 00:30:47,880 --> 00:30:49,280 INDIVIDUALS WHO LEAD SIGNIFICANT 888 00:30:49,280 --> 00:30:51,040 SCIENTIFIC ORGANIZATIONS, THEIR 889 00:30:51,040 --> 00:30:52,600 GROWING CONCERN ABOUT THIS AREA. 890 00:30:52,600 --> 00:30:56,200 AND THERE'S A SENSE AT LEAST 891 00:30:56,200 --> 00:30:57,120 ANECDOTALLY THAT THE CHALLENGE 892 00:30:57,120 --> 00:30:59,560 SEEMS TO BE GROWING, AND THERE 893 00:30:59,560 --> 00:31:03,000 IS SOME DATA TO SUPPORT THIS, 894 00:31:03,000 --> 00:31:04,080 BUT THAT WAS THE ORIGINAL 895 00:31:04,080 --> 00:31:05,520 QUESTION, DID THE DATA ACTUALLY 896 00:31:05,520 --> 00:31:07,040 BEAR THIS OUT. 897 00:31:07,040 --> 00:31:11,280 IF YOU GO TO THE NEXT SLIDE. 898 00:31:11,280 --> 00:31:13,920 SO WE'RE JUST GOING TO SCRATCH 899 00:31:13,920 --> 00:31:14,920 THE SURFACE TO BEGIN TO TALK 900 00:31:14,920 --> 00:31:17,600 ABOUT THIS HERE TODAY, BUT I'LL 901 00:31:17,600 --> 00:31:18,840 BRIEFLY PROVIDE SOME BACKGROUND 902 00:31:18,840 --> 00:31:21,720 DATA FOR CONTEXT. 903 00:31:21,720 --> 00:31:25,200 AS MANY OF YOU KNOW, NSF 904 00:31:25,200 --> 00:31:28,800 COLLECTS DATA ON POSTDOCS AND 905 00:31:28,800 --> 00:31:31,680 CONDUCTS AN ANNUAL CENSUS OF ALL 906 00:31:31,680 --> 00:31:32,640 U.S. ACADEMIC INSTITUTIONS ON 907 00:31:32,640 --> 00:31:36,120 GRANT RESEARCH-BASED MASTERS AND 908 00:31:36,120 --> 00:31:37,760 DOCTORAL DEGREES IN SCIENCE AND 909 00:31:37,760 --> 00:31:38,960 ENGINEERING, AND SELECTED HEALTH 910 00:31:38,960 --> 00:31:40,280 FIELDS AS WELL. 911 00:31:40,280 --> 00:31:42,040 AND NIH ACTUALLY IS A CO-SPONSOR 912 00:31:42,040 --> 00:31:44,200 OF THIS WORK. 913 00:31:44,200 --> 00:31:45,400 AND BASED ON SOME OF THE DATA 914 00:31:45,400 --> 00:31:47,280 THAT THEY HAVE AVAILABLE, YOU 915 00:31:47,280 --> 00:31:49,200 CAN SEE HERE THAT THE NUMBER OF 916 00:31:49,200 --> 00:31:50,440 POSTDOCS WHICH ARE REPRESENTED 917 00:31:50,440 --> 00:31:53,080 BY THE GREEN LINE AND THE NUMBER 918 00:31:53,080 --> 00:31:57,360 OF NON-FACULTY RESEARCHERS WITH 919 00:31:57,360 --> 00:31:58,600 DOCTORATES ARE REPRESENTED IN 920 00:31:58,600 --> 00:32:01,400 THE BLUE LINE, AND I SHOULD NOTE 921 00:32:01,400 --> 00:32:03,680 THAT THESE NFRs, AS THEY ARE 922 00:32:03,680 --> 00:32:06,120 REFERRED TO, THESE NON-FACULTY 923 00:32:06,120 --> 00:32:07,960 RESEARCHERS WITH DOCTORATES, ARE 924 00:32:07,960 --> 00:32:10,080 FOLKS THAT ARE DOCTORATE-HOLDING 925 00:32:10,080 --> 00:32:12,360 STAFF WHO ARE NEITHER POSTDOCS 926 00:32:12,360 --> 00:32:14,480 NOR FACULTY AND ARE PRIMARILY 927 00:32:14,480 --> 00:32:16,120 INVOLVED IN RESEARCH. 928 00:32:16,120 --> 00:32:17,400 BUT YOU CAN SEE HERE THAT THE 929 00:32:17,400 --> 00:32:20,160 NUMBER OF POSTDOCS HAS STEADILY 930 00:32:20,160 --> 00:32:23,000 INCREASED AS A FUNCTION OF TIME 931 00:32:23,000 --> 00:32:23,680 SINCE 1980. 932 00:32:23,680 --> 00:32:25,200 BUT OVER THE LAST DECADE OR SO, 933 00:32:25,200 --> 00:32:28,280 IT'S REMAINED LARGELY FLAT. 934 00:32:28,280 --> 00:32:30,920 AND IMPORTANTLY, I'LL NOTE THAT 935 00:32:30,920 --> 00:32:33,000 THESE NSF DATA WILL BE UPDATED 936 00:32:33,000 --> 00:32:34,280 LATER THIS YEAR, IN DECEMBER, 937 00:32:34,280 --> 00:32:35,640 AND I THINK IT'S GOING TO GIVE 938 00:32:35,640 --> 00:32:36,840 US A REALLY IMPORTANT GLIMPSE 939 00:32:36,840 --> 00:32:38,280 INTO THE IMPACT OF THE PANDEMIC 940 00:32:38,280 --> 00:32:43,080 ON THE POSTDOC WORKFORCE. 941 00:32:43,080 --> 00:32:44,280 WE'LL CONTINUE TO GO TO THE NEXT 942 00:32:44,280 --> 00:32:44,480 SLIDE. 943 00:32:44,480 --> 00:32:47,560 SO IF WE LOOK AT OUR INTERNAL 944 00:32:47,560 --> 00:32:50,200 NIH DATA, YOU CAN SEE THE TRENDS 945 00:32:50,200 --> 00:32:52,520 IN POSTDOCS ON TRAINING GRANTS 946 00:32:52,520 --> 00:32:55,120 AND FELLOWSHIPS HAS STEADILY 947 00:32:55,120 --> 00:32:56,000 DECREASED OVER TIME. 948 00:32:56,000 --> 00:32:58,200 I WILL NOTE THAT WE SEE SORT OF 949 00:32:58,200 --> 00:32:59,480 PARALLELS WHEN YOU LOOK AT THE 950 00:32:59,480 --> 00:33:02,640 NUMBER OF APPLICATIONS FOR THE 951 00:33:02,640 --> 00:33:03,640 F32s. 952 00:33:03,640 --> 00:33:06,400 BECAUSE WE'RE SEEING A SORT OF 953 00:33:06,400 --> 00:33:09,680 SIMILAR DECREASING TREND. 954 00:33:09,680 --> 00:33:10,760 BUT IT'S INTERESTING TO NOTE 955 00:33:10,760 --> 00:33:13,400 THAT THE STIPENDS HAVE ACTUALLY 956 00:33:13,400 --> 00:33:14,520 STEADILY BEEN GROWING OVER THE 957 00:33:14,520 --> 00:33:16,000 LAST 10 OR SO YEARS AND ARE NOW 958 00:33:16,000 --> 00:33:18,520 UP TO ABOUT $55,000 FOR SOMEONE 959 00:33:18,520 --> 00:33:21,920 THAT'S JUST STARTING OUT AS A 960 00:33:21,920 --> 00:33:23,120 POSTDOC, MUCH BETTER THAN WHEN I 961 00:33:23,120 --> 00:33:24,680 STARTED AS A POSTDOC. 962 00:33:24,680 --> 00:33:27,720 BUT YOU KNOW, IN INDUSTRY, THE 963 00:33:27,720 --> 00:33:30,000 NATIONAL AVERAGE IS ABOUT 964 00:33:30,000 --> 00:33:32,000 $20,000 HIGHER, AND THAT'S A 965 00:33:32,000 --> 00:33:33,800 REALLY SIGNIFICANT SALARY 966 00:33:33,800 --> 00:33:35,040 DIFFERENCE THAT WE THINK IS ONE 967 00:33:35,040 --> 00:33:38,840 COMPONENT THAT IS A FACTOR HERE. 968 00:33:38,840 --> 00:33:40,560 IF YOU GO TO THE NEXT SLIDE. 969 00:33:40,560 --> 00:33:42,440 IF YOU LOOK AT WHERE PEOPLE ARE 970 00:33:42,440 --> 00:33:44,840 GOING RIGHT OUT OF GRAD SCHOOL, 971 00:33:44,840 --> 00:33:46,680 WHAT YOU CAN SEE IS THERE IS AN 972 00:33:46,680 --> 00:33:48,120 INCREASING PERCENTAGE OF NEW 973 00:33:48,120 --> 00:33:49,200 PH.D.s THAT ARE GOING INTO 974 00:33:49,200 --> 00:33:52,680 INDUSTRY OR BUSINESS. 975 00:33:52,680 --> 00:33:54,440 IN 2021, LAST YEAR, IT WAS ABOUT 976 00:33:54,440 --> 00:33:55,560 57%. 977 00:33:55,560 --> 00:34:01,000 WHILE ONLY ABOUT 26% A QUARTER 978 00:34:01,000 --> 00:34:02,160 PURSUED CAREERS IN ACADEMIA. 979 00:34:02,160 --> 00:34:03,440 I WANT TO BE CLEAR TO EMPHASIZE 980 00:34:03,440 --> 00:34:05,200 THAT A DISTRIBUTION OF SCIENCE 981 00:34:05,200 --> 00:34:07,160 AND ENGINEERING DOCTORAL 982 00:34:07,160 --> 00:34:08,160 RECIPIENTS GOING INTO A RANGE OF 983 00:34:08,160 --> 00:34:09,400 FIELDS IS A REALLY GOOD THING, 984 00:34:09,400 --> 00:34:11,680 BUT I THINK WE RECOGNIZE THAT 985 00:34:11,680 --> 00:34:13,440 THESE DATA SHOW THAT THERE ARE 986 00:34:13,440 --> 00:34:14,200 TRENDS THAT WARRANT US 987 00:34:14,200 --> 00:34:15,080 CONSIDERING ALL OF THE FACTORS 988 00:34:15,080 --> 00:34:17,920 THAT ARE INFLUENCING PEOPLE'S 989 00:34:17,920 --> 00:34:18,800 DECISION-MAKING AND CONSIDERING 990 00:34:18,800 --> 00:34:22,160 HOW WE MIGHT THINK ABOUT THE 991 00:34:22,160 --> 00:34:26,440 POSTDOCTORAL PATHWAY. 992 00:34:26,440 --> 00:34:28,160 SO NOW I'M GOING TO TURN IT OVER 993 00:34:28,160 --> 00:34:29,400 TO SHELLEY, WHO'S GOING TO SPEAK 994 00:34:29,400 --> 00:34:30,480 MORE ABOUT THIS. 995 00:34:30,480 --> 00:34:30,720 SHELLEY? 996 00:34:30,720 --> 00:34:31,360 >>OKAY, GREAT. 997 00:34:31,360 --> 00:34:32,560 THANK YOU, TARA. 998 00:34:32,560 --> 00:34:35,520 NEXT SLIDE, PLEASE. 999 00:34:35,520 --> 00:34:38,920 SO TARA TOUCHED ON A FEW OF 1000 00:34:38,920 --> 00:34:43,280 THESE ISSUES ALREADY. 1001 00:34:43,280 --> 00:34:49,760 IT SEEMS IN TAKING A LOOK AT 1002 00:34:49,760 --> 00:34:53,120 THIS, YOU KNOW, QUESTION THAT 1003 00:34:53,120 --> 00:34:55,240 IT'S MULTIFACTORIAL, AND I THINK 1004 00:34:55,240 --> 00:34:56,680 A QUESTION THAT WE NEED TO POSE 1005 00:34:56,680 --> 00:34:58,080 IS WHETHER THERE'S AN ONGOING 1006 00:34:58,080 --> 00:35:02,240 CHANGE IN THE TRAJECTORY OF 1007 00:35:02,240 --> 00:35:03,160 GRADUATE STUDENT DECISIONS. 1008 00:35:03,160 --> 00:35:05,720 SO WHAT'S PLAYING INTO THAT, IT 1009 00:35:05,720 --> 00:35:09,240 SEEMS LIKE IT'S A PERFECT STORM. 1010 00:35:09,240 --> 00:35:10,400 I THINK THOSE ARE THE WORDS THAT 1011 00:35:10,400 --> 00:35:14,960 HAVE BEEN USED BY ACTUALLY MANY 1012 00:35:14,960 --> 00:35:17,920 OF THOSE ARTICLES AND OPINION 1013 00:35:17,920 --> 00:35:19,240 PIECES AND OTHER ARTICLES THAT 1014 00:35:19,240 --> 00:35:22,080 HAVE BEEN WRITTEN THAT TARA 1015 00:35:22,080 --> 00:35:25,560 SHOWED AT THE BEGINNING, SORT OF 1016 00:35:25,560 --> 00:35:27,440 REFERRED TO AS A PERFECT STORM, 1017 00:35:27,440 --> 00:35:30,800 PROBABLY BROUGHT TO -- IT'S 1018 00:35:30,800 --> 00:35:31,800 PROBABLY REACHING MORE OF A 1019 00:35:31,800 --> 00:35:34,440 REALLY DRAMATIC DEVELOPMENT, I 1020 00:35:34,440 --> 00:35:38,160 THINK, IT APPEARS, WITH THE 1021 00:35:38,160 --> 00:35:38,960 CORONAVIRUS, BUT IT'S SOMETHING 1022 00:35:38,960 --> 00:35:40,920 THAT'S BEEN DEVELOPING ON -- IT 1023 00:35:40,920 --> 00:35:42,000 SOMETHING THAT I THINK MANY OF 1024 00:35:42,000 --> 00:35:45,280 US ARE INCREASINGLY HEARING FROM 1025 00:35:45,280 --> 00:35:47,920 OUR GRADUATE STUDENTS ABOUT 1026 00:35:47,920 --> 00:35:53,960 WORK/LIFE BALANCE AND OVER THERE 1027 00:35:53,960 --> 00:35:55,360 ON THE RIGHT, AND IT PLAYS INTO 1028 00:35:55,360 --> 00:35:56,800 THE QUESTION OF FINANCIAL 1029 00:35:56,800 --> 00:35:58,240 DECISIONS, AND OF COURSE WE ALL 1030 00:35:58,240 --> 00:36:00,680 KNOW THAT THIS TIME OF LIFE IS A 1031 00:36:00,680 --> 00:36:02,760 CRITICAL TIME FOR MANY PEOPLE, 1032 00:36:02,760 --> 00:36:04,280 THEY'RE GETTING MARRIED STARTING 1033 00:36:04,280 --> 00:36:07,560 FAMILIES AND SO THIS BECOMES A 1034 00:36:07,560 --> 00:36:13,480 REALLY BIG CHALLENGE. 1035 00:36:13,480 --> 00:36:17,080 AND I THINK THAT PLAYING INTO 1036 00:36:17,080 --> 00:36:19,200 THAT IS THE EXTENDING TIME I 1037 00:36:19,200 --> 00:36:21,200 THINK MANY OF US DOCUMENT, AND 1038 00:36:21,200 --> 00:36:22,920 WE'LL SEE THIS, I THINK, IN THE 1039 00:36:22,920 --> 00:36:23,920 DATA, OR WE'RE GOING TO QUESTION 1040 00:36:23,920 --> 00:36:25,800 THIS IN THE DATA, WHETHER THE 1041 00:36:25,800 --> 00:36:29,880 TIME DURING GRAD SCHOOL HAS BEEN 1042 00:36:29,880 --> 00:36:34,080 INCREASING AND THUS EXACERBATING 1043 00:36:34,080 --> 00:36:37,320 THIS PROBLEM, THIS WORK/LIFE 1044 00:36:37,320 --> 00:36:38,280 BALANCE QUESTION IS REALLY 1045 00:36:38,280 --> 00:36:38,720 DEVELOPING. 1046 00:36:38,720 --> 00:36:41,040 AND THEN AT THE BOTTOM, THE 1047 00:36:41,040 --> 00:36:47,920 GLOBAL DIAGRAM IS REFERRING TO 1048 00:36:47,920 --> 00:36:50,440 SOME OF THE CHANGES THAT HAVE 1049 00:36:50,440 --> 00:36:52,760 BEEN EMERGING, HAVE BEEN 1050 00:36:52,760 --> 00:36:54,720 STARTING TO EMERGE AND 1051 00:36:54,720 --> 00:36:55,720 EXACERBATED AGAIN BY THE 1052 00:36:55,720 --> 00:36:59,240 CORONAVIRUS, WHERE THERE ARE 1053 00:36:59,240 --> 00:37:00,120 FEWER INTERNATIONAL POSTDOCS 1054 00:37:00,120 --> 00:37:04,160 THAT ARE COMING TOWARDS THE 1055 00:37:04,160 --> 00:37:04,480 UNITED STATES. 1056 00:37:04,480 --> 00:37:09,040 AND I THINK THAT'S ALSO, YOU 1057 00:37:09,040 --> 00:37:10,000 KNOW, ONE POSSIBILITY THAT WE'LL 1058 00:37:10,000 --> 00:37:14,280 LOOK INTO, IS WHETHER THE LEVEL 1059 00:37:14,280 --> 00:37:17,920 OF SCIENCE IS ACTUALLY 1060 00:37:17,920 --> 00:37:19,440 IMPROVING, I THINK, IN OTHER 1061 00:37:19,440 --> 00:37:21,080 PARTS OF THE WORLD, I THINK WE 1062 00:37:21,080 --> 00:37:22,400 KIND OF NEED TO LOOK AT THAT, 1063 00:37:22,400 --> 00:37:27,800 AND THE HOME-GROWN TALENT, THE 1064 00:37:27,800 --> 00:37:31,000 RETURN OF POSTDOCS FROM THE 1065 00:37:31,000 --> 00:37:32,920 UNITED STATES TO THEIR HOME 1066 00:37:32,920 --> 00:37:33,920 COUNTRIES AND DEVELOPING SCIENCE 1067 00:37:33,920 --> 00:37:34,480 THERE. 1068 00:37:34,480 --> 00:37:35,560 WHICH IS A GOOD THING. 1069 00:37:35,560 --> 00:37:38,960 I MEAN, I THINK THE UNITED 1070 00:37:38,960 --> 00:37:43,120 STATES HAS BEEN A REAL BEACON OF 1071 00:37:43,120 --> 00:37:47,360 TRAINING, AND SO THAT'S 1072 00:37:47,360 --> 00:37:48,960 AFFECTED, I THINK, DECISIONS 1073 00:37:48,960 --> 00:37:50,480 WORLDWIDE. 1074 00:37:50,480 --> 00:37:53,200 OKAY, SO NEXT SLIDE THEN. 1075 00:37:53,200 --> 00:37:54,760 REALLY THE PROPOSED WORKING 1076 00:37:54,760 --> 00:38:00,400 GROUP THAT WE'VE DEVELOPED ABOUT 1077 00:38:00,400 --> 00:38:01,080 FIVE MAJOR CONSIDERATIONS THAT 1078 00:38:01,080 --> 00:38:06,120 WE'D LIKE TO DISCUSS IN THE 1079 00:38:06,120 --> 00:38:06,800 WORKING GROUP. 1080 00:38:06,800 --> 00:38:10,120 ONE IS TO EVALUATE THE EVIDENCE 1081 00:38:10,120 --> 00:38:12,480 OF THIS PERCEIVED SHORTAGE IN 1082 00:38:12,480 --> 00:38:15,560 PH.D.s THAT ARE SEEKING U.S. 1083 00:38:15,560 --> 00:38:15,920 POSTDOCS. 1084 00:38:15,920 --> 00:38:19,840 SO I THINK THE PERCEPTION IS 1085 00:38:19,840 --> 00:38:21,600 INCREASING, AND WE DEFINITELY 1086 00:38:21,600 --> 00:38:23,560 WANT TO -- YOU KNOW, ONE OF THE 1087 00:38:23,560 --> 00:38:27,400 MAJOR QUESTIONS OR WHAT ARE THE 1088 00:38:27,400 --> 00:38:28,400 DATA TO SUPPORT THAT. 1089 00:38:28,400 --> 00:38:29,600 YOU SAW A LITTLE BIT OF THAT 1090 00:38:29,600 --> 00:38:31,800 FROM TARA'S LAST DATA SLIDE, 1091 00:38:31,800 --> 00:38:35,080 WHERE THERE'S A DECREASED NUMBER 1092 00:38:35,080 --> 00:38:37,840 OF GRADUATE STUDENTS CHOOSING TO 1093 00:38:37,840 --> 00:38:39,880 CONTINUE INTO POSTDOCS. 1094 00:38:39,880 --> 00:38:42,520 THE SECOND ONE IS TO ASSESS AND 1095 00:38:42,520 --> 00:38:44,920 CONSIDER FACTORS INFLUENCING THE 1096 00:38:44,920 --> 00:38:47,040 SCOPE AND PERSISTENCE OF THE 1097 00:38:47,040 --> 00:38:50,000 ISSUE, AND SO HERE ALL OF THESE 1098 00:38:50,000 --> 00:38:53,720 POINTS THAT WE WERE JUST 1099 00:38:53,720 --> 00:38:59,520 DISCUSSING, WORK/LIFE BALANCE, 1100 00:38:59,520 --> 00:39:00,720 CHANGES IN -- YOU KNOW, I WOULD 1101 00:39:00,720 --> 00:39:04,000 SAY THE EMERGENCE OF A LOT OF 1102 00:39:04,000 --> 00:39:06,080 OPPORTUNITY IN INDUSTRY AND 1103 00:39:06,080 --> 00:39:07,680 BIOTECH, WHICH AS TARA MENTIONED 1104 00:39:07,680 --> 00:39:10,040 IS A GREAT THING, BUT WE JUST 1105 00:39:10,040 --> 00:39:14,240 NEED TO EVALUATE THE IMPACT OF 1106 00:39:14,240 --> 00:39:17,480 THAT ON GRADUATE STUDIES AND THE 1107 00:39:17,480 --> 00:39:20,800 DISPARITY IN THE AMOUNT OF 1108 00:39:20,800 --> 00:39:22,360 COMPENSATION IN THOSE SPHERES, 1109 00:39:22,360 --> 00:39:24,320 SO HOW IS THAT AFFECTING 1110 00:39:24,320 --> 00:39:27,440 DECISIONS. 1111 00:39:27,440 --> 00:39:28,760 SO REVIEW AND COMPARE OTHER 1112 00:39:28,760 --> 00:39:29,960 APPROACHES TO POSTDOCTORAL 1113 00:39:29,960 --> 00:39:32,280 TRAINING, SO HERE WE WANT TO 1114 00:39:32,280 --> 00:39:33,560 EVALUATE WHAT OTHER COUNTRIES 1115 00:39:33,560 --> 00:39:42,040 MIGHT BE DOING AND, YOU KNOW, 1116 00:39:42,040 --> 00:39:44,320 CONSIDERATIONS SUCH AS THAT. 1117 00:39:44,320 --> 00:39:49,880 FOURTH, CONSIDER WAYS TO SUPPORT 1118 00:39:49,880 --> 00:39:51,480 POSTDOCS' QUALITY OF LIFE AND 1119 00:39:51,480 --> 00:39:52,280 WORK-LIFE BALANCE. 1120 00:39:52,280 --> 00:39:53,680 HERE WE'RE DISCUSSING WAYS -- WE 1121 00:39:53,680 --> 00:39:55,320 WANT TO THINK OUTSIDE OF THE BOX 1122 00:39:55,320 --> 00:39:56,480 AND CONSIDER WAYS TO ENHANCE 1123 00:39:56,480 --> 00:40:00,320 QUALITY OF LIFE AND WORK-LIFE 1124 00:40:00,320 --> 00:40:04,000 BALANCE, AND HOW WE MIGHT 1125 00:40:04,000 --> 00:40:04,920 APPROACH THAT. 1126 00:40:04,920 --> 00:40:07,760 WE'RE ALREADY THINKING OF 1127 00:40:07,760 --> 00:40:09,600 VARIOUS WAYS THAT MIGHT BE 1128 00:40:09,600 --> 00:40:09,840 POSSIBLE. 1129 00:40:09,840 --> 00:40:12,000 AND THEN FINALLY, TO ENGAGE KEY 1130 00:40:12,000 --> 00:40:13,560 INTERNAL AND EXTERNAL 1131 00:40:13,560 --> 00:40:16,640 STAKEHOLDERS, SO HERE WE -- I 1132 00:40:16,640 --> 00:40:18,600 THINK WE HAVE THIS ON THE NEXT 1133 00:40:18,600 --> 00:40:20,840 SLIDE SO I THINK WE CAN PLACE OY 1134 00:40:20,840 --> 00:40:21,480 GO TO THAT. 1135 00:40:21,480 --> 00:40:24,240 SO MYSELF AND TARA, WE'RE GOING 1136 00:40:24,240 --> 00:40:26,000 TO CO-CHAIR THIS PROPOSED 1137 00:40:26,000 --> 00:40:29,920 WORKING GROUP. 1138 00:40:29,920 --> 00:40:32,120 TARA HAS A GREAT TEAM WHO HAVE 1139 00:40:32,120 --> 00:40:36,160 ALREADY BEEN HELPING US 1140 00:40:36,160 --> 00:40:37,960 ENORMOUSLY, JOEL ISLAM AND LAURA 1141 00:40:37,960 --> 00:40:40,880 LONG, SO THANK THEM FOR THE HELP 1142 00:40:40,880 --> 00:40:42,000 THEY'VE ALREADY GIVEN US TO 1143 00:40:42,000 --> 00:40:44,960 DEVELOP THE FIRST PLOTS HERE. 1144 00:40:44,960 --> 00:40:50,200 AND OUR PROPOSED MEMBERSHIP 1145 00:40:50,200 --> 00:40:52,920 WOULD BE ACD MEMBERS. 1146 00:40:52,920 --> 00:40:53,600 NIH MEMBERS. 1147 00:40:53,600 --> 00:40:56,000 WE'D LIKE TO INVOLVE POSTDOCS 1148 00:40:56,000 --> 00:40:56,680 AND GRADUATE STUDENTS. 1149 00:40:56,680 --> 00:40:58,320 I THINK THIS IS ABSOLUTELY 1150 00:40:58,320 --> 00:41:00,080 CRUCIAL RIGHT NOW. 1151 00:41:00,080 --> 00:41:01,840 AND SO WHERE TO GET THEM AND HOW 1152 00:41:01,840 --> 00:41:03,920 TO GET THEM, WE'VE BEEN 1153 00:41:03,920 --> 00:41:05,320 DISCUSSING THAT. 1154 00:41:05,320 --> 00:41:09,520 EARLY CAREER INVESTIGATORS. 1155 00:41:09,520 --> 00:41:13,120 THEY'RE CERTAINLY -- WELL, THE 1156 00:41:13,120 --> 00:41:14,400 FEELING IS THAT A PREVIOUS 1157 00:41:14,400 --> 00:41:16,200 WORKING GROUP HAS HAD A BIG 1158 00:41:16,200 --> 00:41:20,320 IMPACT THERE, AND IT'S VERY -- I 1159 00:41:20,320 --> 00:41:21,640 THINK IT WILL BE VERY 1160 00:41:21,640 --> 00:41:23,920 INTERESTING TO INVOLVE EARLY 1161 00:41:23,920 --> 00:41:25,920 CAREER INVESTIGATORS TO DISCUSS 1162 00:41:25,920 --> 00:41:28,480 THIS ISSUE, AND OF COURSE THEIR 1163 00:41:28,480 --> 00:41:32,200 CAREERS ARE VERY MUCH DEPENDENT 1164 00:41:32,200 --> 00:41:33,800 ON BRINGING IN TRAINEES, SO 1165 00:41:33,800 --> 00:41:35,480 HAVING THEM INVOLVED WILL BE 1166 00:41:35,480 --> 00:41:36,000 REALLY IMPORTANT. 1167 00:41:36,000 --> 00:41:40,040 WE WANT TO INVOLVE ACADEMIC 1168 00:41:40,040 --> 00:41:46,600 ORGANIZATIONS THAT ARE -- ALL 1169 00:41:46,600 --> 00:41:48,200 SORTS OF ACADEMIC ORGANIZATIONS 1170 00:41:48,200 --> 00:41:54,000 INCLUDING VARIOUS UNIVERSITIES 1171 00:41:54,000 --> 00:41:55,400 AND OTHER RESEARCH INSTITUTIONS 1172 00:41:55,400 --> 00:41:58,360 THAT ARE NOT UNIVERSITIES, 1173 00:41:58,360 --> 00:41:59,880 THEY'RE PARTICULARLY DEPENDENT 1174 00:41:59,880 --> 00:42:01,760 ACTUALLY ON POSTDOCS, SO IT WILL 1175 00:42:01,760 --> 00:42:03,280 BE IMPORTANT TO INVOLVE OTHER 1176 00:42:03,280 --> 00:42:07,440 SORTS OF ORGANIZATIONS. 1177 00:42:07,440 --> 00:42:09,560 POSTDOC, I THINK POSTDOC WE LEFT 1178 00:42:09,560 --> 00:42:13,360 OUT A WORD, AND GRADUATE STUDENT 1179 00:42:13,360 --> 00:42:14,160 ASSOCIATIONS BECAUSE WE NEED 1180 00:42:14,160 --> 00:42:15,160 THEIR HELP IN THE DATA 1181 00:42:15,160 --> 00:42:16,800 COLLECTION AND UNDERSTANDING THE 1182 00:42:16,800 --> 00:42:20,760 IMPACT OF THESE ISSUES. 1183 00:42:20,760 --> 00:42:23,400 AND TARA SUGGESTED, AND I THINK 1184 00:42:23,400 --> 00:42:25,920 IT'S A GREAT IDEA, TO INVOLVE 1185 00:42:25,920 --> 00:42:33,440 ECONOMISTS TO SEE -- TO BRING IN 1186 00:42:33,440 --> 00:42:34,400 PEOPLE TO LOOK AT THE FINANCES 1187 00:42:34,400 --> 00:42:35,800 HERE AND START TO THINK ABOUT 1188 00:42:35,800 --> 00:42:38,760 WHAT CAN WE DO AND WHAT SORT OF 1189 00:42:38,760 --> 00:42:42,560 APPROACHES WE CAN USE TO ADDRESS 1190 00:42:42,560 --> 00:42:44,440 SOME OF THE FINANCIAL ISSUES 1191 00:42:44,440 --> 00:42:45,640 INVOLVED THAT I THINK ARE FRONT 1192 00:42:45,640 --> 00:42:46,960 AND CENTER, TO BE HONEST ABOUT 1193 00:42:46,960 --> 00:42:48,600 IT AND FRANK. 1194 00:42:48,600 --> 00:42:53,360 SO I GUESS NEXT SLIDE. 1195 00:42:53,360 --> 00:42:55,000 HERE IS OUR PLAN. 1196 00:42:55,000 --> 00:42:56,560 TODAY WE'RE INVITING WORKING 1197 00:42:56,560 --> 00:43:00,040 GROUP MEMBERS, BOTH WITHIN THE 1198 00:43:00,040 --> 00:43:04,800 ACD AND WE'RE DEVELOPING A 1199 00:43:04,800 --> 00:43:06,000 SPREADSHEET OF OTHER POSSIBLE 1200 00:43:06,000 --> 00:43:09,280 MEMBERS TO INVOLVE. 1201 00:43:09,280 --> 00:43:11,680 WE WANT TO DISCUSS THIS IN MUCH 1202 00:43:11,680 --> 00:43:13,200 GREATER DETAIL IN THE NEXT ACD 1203 00:43:13,200 --> 00:43:15,160 MEETING IN DECEMBER, AND 1204 00:43:15,160 --> 00:43:17,040 THEREAFTER, WE WILL START OUR 1205 00:43:17,040 --> 00:43:21,760 MEETINGS AND THE HEAVY LIFTING 1206 00:43:21,760 --> 00:43:26,480 AND ADDRESSING THESE ISSUES. 1207 00:43:26,480 --> 00:43:27,120 WE'LL DRAFT RECOMMENDATIONS IN 1208 00:43:27,120 --> 00:43:28,000 JUNE AND HAVE FINAL 1209 00:43:28,000 --> 00:43:30,200 RECOMMENDATIONS IN 1210 00:43:30,200 --> 00:43:30,560 DECEMBER 2023. 1211 00:43:30,560 --> 00:43:32,080 SO NEXT SLIDE, PLEASE. 1212 00:43:32,080 --> 00:43:34,480 SO NOW WE'D LIKE TO OPEN IT UP 1213 00:43:34,480 --> 00:43:36,640 FOR YOUR THOUGHTS, ANY QUESTIONS 1214 00:43:36,640 --> 00:43:38,880 THAT YOU HAVE, AND FIRE AWAY. 1215 00:43:38,880 --> 00:43:42,960 WE'D LOVE TO HAVE YOU. 1216 00:43:42,960 --> 00:43:45,160 >>THANKS, SHELLEY. 1217 00:43:45,160 --> 00:43:47,280 TO YOUR POINT EARLIER, ALREADY 1218 00:43:47,280 --> 00:43:49,440 GETTING EMAILS FROM FOLKS 1219 00:43:49,440 --> 00:43:52,320 VOLUNTEERING TO BE ON THE GROUP. 1220 00:43:52,320 --> 00:43:52,520 SO -- 1221 00:43:52,520 --> 00:43:53,280 >>WONDERFUL. 1222 00:43:53,280 --> 00:43:55,160 >>KEEP THEM COMING AND IF YOU 1223 00:43:55,160 --> 00:43:56,920 HAVE OTHER SUGGESTIONS, EVEN IF 1224 00:43:56,920 --> 00:43:58,240 YOU YOURSELF DO NOT WANT TO BE 1225 00:43:58,240 --> 00:43:59,760 IN THE GROUP OR NOT VOLUNTEERING 1226 00:43:59,760 --> 00:44:00,880 TO BE ON THE GROUP, WE'RE OPEN 1227 00:44:00,880 --> 00:44:01,280 TO THAT. 1228 00:44:01,280 --> 00:44:01,960 >>YES. 1229 00:44:01,960 --> 00:44:03,960 >>JUDITH, I SEE YOUR HAND 1230 00:44:03,960 --> 00:44:11,640 RAISED. 1231 00:44:11,640 --> 00:44:13,200 >>SO I THINK THERE ARE SORT OF 1232 00:44:13,200 --> 00:44:14,640 TWO SIDES TO THIS COIN. 1233 00:44:14,640 --> 00:44:16,560 ONE IS THE CONCERN ABOUT THE 1234 00:44:16,560 --> 00:44:18,760 POSTDOCS, AND THE OTHER IS THE 1235 00:44:18,760 --> 00:44:19,880 CONCERN ABOUT THE INVESTIGATORS 1236 00:44:19,880 --> 00:44:24,720 WHO AREN'T GETTING POSTDOCS. 1237 00:44:24,720 --> 00:44:26,760 AND ONE GROUP THAT I DIDN'T HEAR 1238 00:44:26,760 --> 00:44:28,400 MENTIONED IN YOUR PRESENTATION 1239 00:44:28,400 --> 00:44:33,440 WAS SENIOR SCIENTISTS. 1240 00:44:33,440 --> 00:44:34,880 I WONDER IF YOUR WORKING GROUP 1241 00:44:34,880 --> 00:44:37,840 IS PLANNING TO CONSIDER HOW TO 1242 00:44:37,840 --> 00:44:39,280 FOSTER THAT TRACK IN A MORE 1243 00:44:39,280 --> 00:44:40,280 EFFECTIVE WAY. 1244 00:44:40,280 --> 00:44:42,360 >>I'LL TAKE THAT. 1245 00:44:42,360 --> 00:44:42,840 ABSOLUTELY. 1246 00:44:42,840 --> 00:44:46,280 I THINK THAT'S A REALLY 1247 00:44:46,280 --> 00:44:47,160 IMPORTANT CONSIDERATION, HOW 1248 00:44:47,160 --> 00:44:47,960 WE'RE GOING TO DEVELOP THIS 1249 00:44:47,960 --> 00:44:49,680 TRACK. 1250 00:44:49,680 --> 00:44:52,320 PROBABLY -- YOU KNOW, TRY TO 1251 00:44:52,320 --> 00:44:57,720 ENHANCE THAT WITHIN ACADEMIA AND 1252 00:44:57,720 --> 00:45:03,360 PROVIDE -- I HOPE WE CAN FIND 1253 00:45:03,360 --> 00:45:05,080 WAYS TO PROVIDE THEM MORE 1254 00:45:05,080 --> 00:45:10,000 AUTONOMY AND MORE RESOURCES TO 1255 00:45:10,000 --> 00:45:11,560 HELP THEM TO ATTRACT POSTDOCS. 1256 00:45:11,560 --> 00:45:13,400 I ALSO WANT TO SAY -- WE DIDN'T 1257 00:45:13,400 --> 00:45:15,440 REALLY DISCUSS IT, THIS WAS VERY 1258 00:45:15,440 --> 00:45:20,200 CURRCURSORY, WHAT WE PRESENTED,T 1259 00:45:20,200 --> 00:45:21,800 ONE CONSIDERATION IN ADDITION TO 1260 00:45:21,800 --> 00:45:24,200 THAT, JUDITH, THE BIG THIRD 1261 00:45:24,200 --> 00:45:26,840 CATEGORY IS LOST -- WORRYING 1262 00:45:26,840 --> 00:45:29,320 ABOUT LOST BRAIN POWER INTO 1263 00:45:29,320 --> 00:45:30,360 ACADEMIA, INTO THE FUTURE. 1264 00:45:30,360 --> 00:45:34,160 I'M VERY CONCERNED ABOUT THAT. 1265 00:45:34,160 --> 00:45:37,240 WHAT'S GOING TO HAPPEN GOING 1266 00:45:37,240 --> 00:45:40,440 FORWARD . 1267 00:45:40,440 --> 00:45:42,400 I THINK ACADEMIA PROVIDES A LOT 1268 00:45:42,400 --> 00:45:44,480 OF RAW MATERIAL FOR INDUSTRY AND 1269 00:45:44,480 --> 00:45:45,520 BIOTECH, AND I THINK WE DON'T 1270 00:45:45,520 --> 00:45:46,280 WANT TO LOSE THAT. 1271 00:45:46,280 --> 00:45:48,800 A LOT OF SEED IDEAS AND SEED 1272 00:45:48,800 --> 00:45:54,400 KNOWLEDGE COME FROM ACADEMIA. 1273 00:45:54,400 --> 00:45:54,880 SO THANK YOU. 1274 00:45:54,880 --> 00:45:56,480 >>THANK YOU, SHELLEY. 1275 00:45:56,480 --> 00:45:57,880 WE ARE AT TIME AND I WANT TO 1276 00:45:57,880 --> 00:46:03,280 MAKE SURE THAT WE GIVE 1277 00:46:03,280 --> 00:46:07,880 SUFFICIENT TIME FOR THE NEXT 1278 00:46:07,880 --> 00:46:08,200 PRESENTATION. 1279 00:46:08,200 --> 00:46:09,200 >>THERE'S A VERY IMPORTANT 1280 00:46:09,200 --> 00:46:13,680 COMMENT IN THE CHAT BOX. 1281 00:46:13,680 --> 00:46:15,560 PERHAPS YOU COULD ARTICULATE 1282 00:46:15,560 --> 00:46:16,880 THAT FOR THOSE WHO CAN'T SEE THE 1283 00:46:16,880 --> 00:46:20,280 CHAT BOX, BECAUSE THAT'S A VERY 1284 00:46:20,280 --> 00:46:20,640 IMPORTANT POINT. 1285 00:46:20,640 --> 00:46:23,600 PLEASE. 1286 00:46:23,600 --> 00:46:25,640 >>YEAH, THERE'S A LOT OF 1287 00:46:25,640 --> 00:46:26,440 COMPLEXITIES RIGHT NOW THAT 1288 00:46:26,440 --> 00:46:31,120 WE'VE ALL BEEN SEEING IN GETTING 1289 00:46:31,120 --> 00:46:33,880 VISAS FOR INTERNATIONAL STUDENTS 1290 00:46:33,880 --> 00:46:34,920 AND INTERNATIONAL POSTDOCS. 1291 00:46:34,920 --> 00:46:36,200 THIS IS GOING TO BE SOMETHING WE 1292 00:46:36,200 --> 00:46:38,600 WILL HAVE TO ADDRESS, I THINK AS 1293 00:46:38,600 --> 00:46:41,720 PART OF THE WORKING GROUP. 1294 00:46:41,720 --> 00:46:45,400 >>AND THANKS FOR THE 1295 00:46:45,400 --> 00:46:46,160 SUGGESTION, FOR INCLUDING 1296 00:46:46,160 --> 00:46:47,480 SOMEONE WHO CAN REPRESENT THAT 1297 00:46:47,480 --> 00:46:48,480 VIEWPOINT. 1298 00:46:48,480 --> 00:46:50,520 >>THERE ARE PEOPLE WHO KNOW THE 1299 00:46:50,520 --> 00:46:52,120 INS AND OUTS OF THE COMPLEXITY, 1300 00:46:52,120 --> 00:46:54,080 SO I THINK IT WOULD BE GOOD TO 1301 00:46:54,080 --> 00:46:54,600 HAVE THEM INCLUDED. 1302 00:46:54,600 --> 00:46:55,560 THANK YOU. 1303 00:46:55,560 --> 00:46:56,840 >>THAT'S A GREAT SUGGESTION. 1304 00:46:56,840 --> 00:47:01,800 >>THANK YOU. 1305 00:47:01,800 --> 00:47:02,880 >>OKAY. 1306 00:47:02,880 --> 00:47:04,160 I'LL LOOK FORWARD TO MORE 1307 00:47:04,160 --> 00:47:04,840 DISCUSSION IN DECEMBER. 1308 00:47:04,840 --> 00:47:05,520 THANK YOU, SHELLEY. 1309 00:47:05,520 --> 00:47:06,800 >>THANK YOU. 1310 00:47:06,800 --> 00:47:09,520 >>WE WILL SHIFT GEARS NOW TO 1311 00:47:09,520 --> 00:47:11,120 ANOTHER PROPOSED ACD WORKING 1312 00:47:11,120 --> 00:47:13,920 GROUP THAT WE'RE PUTTING 1313 00:47:13,920 --> 00:47:15,360 FORWARD, AND THAT IS GOING TO BE 1314 00:47:15,360 --> 00:47:17,680 FOCUSED ON NOVEL ALTERNATIVE 1315 00:47:17,680 --> 00:47:22,400 MODELS AND METHODS THAT WE'VE 1316 00:47:22,400 --> 00:47:23,800 ASKED LYRIC JORGENSON AND HOWARD 1317 00:47:23,800 --> 00:47:25,320 CHANG TO CO-CHAIR, AND I THINK 1318 00:47:25,320 --> 00:47:27,000 HOWARD IS UNAVAILABLE TODAY, SO 1319 00:47:27,000 --> 00:47:30,920 LYRIC, YOU ARE GOING TO BE 1320 00:47:30,920 --> 00:47:34,320 PRESENTING, CORRECT? 1321 00:47:34,320 --> 00:47:39,200 SO TAKE IT AWAY. 1322 00:47:39,200 --> 00:47:42,320 >>SORRY, I WAS TRAPPED ON MUTE. 1323 00:47:42,320 --> 00:47:43,760 AND HOWARD CERTAINLY SENDS HIS 1324 00:47:43,760 --> 00:47:44,120 REGRETS. 1325 00:47:44,120 --> 00:47:45,720 HE HAD AN UNAVOIDABLE COULD BE 1326 00:47:45,720 --> 00:47:50,760 FLICT BUT IS PCONFLICTBUT IS PLG 1327 00:47:50,760 --> 00:47:51,960 THIS GROUP ALONG WITH MYSELF BUT 1328 00:47:51,960 --> 00:47:53,400 WE WILL SEE HIM IN DECEMBER AND 1329 00:47:53,400 --> 00:47:55,640 HE IS GOING TO BE A VALUABLE 1330 00:47:55,640 --> 00:47:57,720 CONTRIBUTOR. 1331 00:47:57,720 --> 00:48:00,320 SO AS EVERYONE KNOWS, HERE AT 1332 00:48:00,320 --> 00:48:02,120 NIH, WE HAVE THE BASIC MISSION 1333 00:48:02,120 --> 00:48:05,840 OF FUNDING RESEARCH THAT RELIES 1334 00:48:05,840 --> 00:48:07,840 ON A COMBINATION OF METHODS, 1335 00:48:07,840 --> 00:48:08,560 METHODOLOGIES AND TECHNOLOGIES 1336 00:48:08,560 --> 00:48:10,680 THAT REALLY HELP US EXPLORE 1337 00:48:10,680 --> 00:48:12,960 QUESTIONS ABOUT HUMAN HEALTH AND 1338 00:48:12,960 --> 00:48:13,880 DISEASE. 1339 00:48:13,880 --> 00:48:16,160 THESE APPROACHES EMPLOY A BROAD 1340 00:48:16,160 --> 00:48:17,720 PORTFOLIO OF MAMMALIAN, 1341 00:48:17,720 --> 00:48:18,720 NON-MAMMALIAN AND OF COURSE 1342 00:48:18,720 --> 00:48:20,360 NON-ANIMAL MODELS AND METHODS. 1343 00:48:20,360 --> 00:48:22,320 ANIMAL RESEARCH, PARTICULARLY IN 1344 00:48:22,320 --> 00:48:23,640 MAMMALS, COMES THE CLOSEST TO 1345 00:48:23,640 --> 00:48:25,880 MODELING THE COMPLEXITY OF 1346 00:48:25,880 --> 00:48:27,520 BIOLOGY AND DISEASE CIRCUIT AND 1347 00:48:27,520 --> 00:48:28,480 SYSTEMS, HOWEVER, WE'RE 1348 00:48:28,480 --> 00:48:30,200 CERTAINLY FINDING THAT NEWER AND 1349 00:48:30,200 --> 00:48:32,160 CLEARLY MORE SOPHISTICATED 1350 00:48:32,160 --> 00:48:33,440 METHODOLOGIES AND TECHNOLOGIES 1351 00:48:33,440 --> 00:48:34,680 ARE REALLY TRANSFORMING THE 1352 00:48:34,680 --> 00:48:36,560 CONDUCT OF SCIENCE IN A VARIETY 1353 00:48:36,560 --> 00:48:37,040 OF AREAS. 1354 00:48:37,040 --> 00:48:38,320 SO THESE METHODS ARE BEING 1355 00:48:38,320 --> 00:48:40,320 DEVELOPED AND APPLIED IN A WIDE 1356 00:48:40,320 --> 00:48:42,160 ARRAY OF AREAS, INCLUDING 1357 00:48:42,160 --> 00:48:44,880 DISEASE MODELS SUCH AS CANCER, 1358 00:48:44,880 --> 00:48:46,680 DIABETES, CARDIOVASCULAR 1359 00:48:46,680 --> 00:48:48,000 DISEASE, ALZHEIMER'S DISEASE, 1360 00:48:48,000 --> 00:48:50,960 MENTAL ILLNESS, I INFECTIOUS 1361 00:48:50,960 --> 00:48:51,880 DISEASE AND MORE. 1362 00:48:51,880 --> 00:48:53,480 AMAZINGLY AS YOU CAN SEE FROM 1363 00:48:53,480 --> 00:48:55,560 ONE OF THE ARTICLES, EVEN BEING 1364 00:48:55,560 --> 00:48:57,200 USED ON THE INTERNATIONAL SPACE 1365 00:48:57,200 --> 00:48:58,560 STATION TO STUDY HUMAN IMMUNE 1366 00:48:58,560 --> 00:48:59,000 FUNCTION. 1367 00:48:59,000 --> 00:49:00,400 SO IT'S CLEAR THAT THESE 1368 00:49:00,400 --> 00:49:02,520 INNOVATIVE APPROACHES HOLD GREAT 1369 00:49:02,520 --> 00:49:04,520 PROMISE FOR THE FUTURE OF 1370 00:49:04,520 --> 00:49:05,480 BIOMEDICAL RESEARCH. 1371 00:49:05,480 --> 00:49:09,120 IN DIFFERENT CONTEXTS, SOME OF 1372 00:49:09,120 --> 00:49:11,080 THESE NEWER METHODOLOGIES 1373 00:49:11,080 --> 00:49:12,720 ESPECIALLY THOSE THAT 1374 00:49:12,720 --> 00:49:14,040 INCORPORATE THE 3Rs, REPLACE, 1375 00:49:14,040 --> 00:49:15,520 REDUCE AND REFINE, HAVE BEEN 1376 00:49:15,520 --> 00:49:17,680 REFERRED TO AS ALTERNATIVE 1377 00:49:17,680 --> 00:49:19,560 METHODS OR NEW APPROACH 1378 00:49:19,560 --> 00:49:19,880 METHODOLOGIES. 1379 00:49:19,880 --> 00:49:20,600 WE RECOGNIZE THESE APPROACHES 1380 00:49:20,600 --> 00:49:22,560 ARE ACTUALLY COMPLEMENTARY TO 1381 00:49:22,560 --> 00:49:24,720 THE TRADITIONAL MODELS THAT WE 1382 00:49:24,720 --> 00:49:26,120 EMPLOY ALREADY AND THEY REFLECT 1383 00:49:26,120 --> 00:49:27,320 AN ESSENTIAL TOOL FOR INCREASING 1384 00:49:27,320 --> 00:49:28,880 OUR CAPABILITIES TO STUDY 1385 00:49:28,880 --> 00:49:29,640 BIOLOGICAL SYSTEMS. 1386 00:49:29,640 --> 00:49:30,400 HOWEVER, WE'RE GOING TO CHOOSE 1387 00:49:30,400 --> 00:49:32,360 TO USE THIS TERM, NOVEL 1388 00:49:32,360 --> 00:49:34,600 ALTERNATIVE METHODS, TO REALLY 1389 00:49:34,600 --> 00:49:35,800 ENCOMPASS THIS CATEGORY OF 1390 00:49:35,800 --> 00:49:37,120 RESEARCH METHODS FOR THE 1391 00:49:37,120 --> 00:49:39,040 PURPOSES OF CONSISTENCY WITH OUR 1392 00:49:39,040 --> 00:49:42,320 PARTNERS WORKING IN THIS AREA. 1393 00:49:42,320 --> 00:49:44,640 SO IT SHOULDN'T BE SURPRISING TO 1394 00:49:44,640 --> 00:49:46,520 ANYONE THAT NIH HAS A REALLY 1395 00:49:46,520 --> 00:49:47,480 ROBUST INVESTMENT IN THESE TYPES 1396 00:49:47,480 --> 00:49:48,760 OF TOOLS AND TECHNOLOGIES WHICH 1397 00:49:48,760 --> 00:49:51,080 CAN BE BROADLY CATEGORIZED IN 1398 00:49:51,080 --> 00:49:53,560 THREE DIFFERENT AREAS. 1399 00:49:53,560 --> 00:49:55,760 FIRST, IN CHEMICO STRATEGIES, 1400 00:49:55,760 --> 00:49:57,320 THESE ARE REALLY EXPERIMENTS ON 1401 00:49:57,320 --> 00:49:59,400 BIOLOGICAL MOLECULES LIKE DNA 1402 00:49:59,400 --> 00:50:01,720 AND PROTEINS AND TEST TUBES. 1403 00:50:01,720 --> 00:50:03,400 THE SECOND CATEGORY IS IN VITRO 1404 00:50:03,400 --> 00:50:04,720 METHODS SUCH AS EXPLORING THE 1405 00:50:04,720 --> 00:50:06,440 NATURE OF CELLS AND TISSUES BY 1406 00:50:06,440 --> 00:50:07,800 CULTURING THEM IN STERILE 1407 00:50:07,800 --> 00:50:08,480 CHAMBERS. 1408 00:50:08,480 --> 00:50:11,200 AND THE THIRD CATEGORY ARE 1409 00:50:11,200 --> 00:50:12,400 INSILICO MODEL, WHICH THESE 1410 00:50:12,400 --> 00:50:13,600 TYPICALLY EMPLOY COMPUTATIONAL 1411 00:50:13,600 --> 00:50:15,240 MODELS THAT SIMULATE HOW 1412 00:50:15,240 --> 00:50:18,560 BIOLOGICAL SYSTEMS WORK AND 1413 00:50:18,560 --> 00:50:20,840 PREDICT OUTCOMES TO REFINE 1414 00:50:20,840 --> 00:50:21,520 HYPOTHESES. 1415 00:50:21,520 --> 00:50:22,720 SO IMPORTANTLY I'D LIKE TO 1416 00:50:22,720 --> 00:50:23,280 EMPHASIZE THAT NIH HAS BEEN 1417 00:50:23,280 --> 00:50:25,920 WORKING WITH THESE MODELS SINCE 1418 00:50:25,920 --> 00:50:27,160 ITS FOUNDATION AND CURRENTLY 1419 00:50:27,160 --> 00:50:27,920 THROUGH THE PRESENT DAY. 1420 00:50:27,920 --> 00:50:30,000 WE'VE ACTUALLY SEEN A DRAMATIC 1421 00:50:30,000 --> 00:50:31,920 INCREASE IN THE LAST 15 YEARS IN 1422 00:50:31,920 --> 00:50:33,960 OUR INVESTMENT IN THESE TYPES OF 1423 00:50:33,960 --> 00:50:35,080 APPROACHES, AND THEY'LL CONTINUE 1424 00:50:35,080 --> 00:50:36,160 TO TRANSFORM THE SCIENCE THAT WE 1425 00:50:36,160 --> 00:50:39,720 DO. 1426 00:50:39,720 --> 00:50:40,920 CAVEAT, THOUGH, OF COURSE IS 1427 00:50:40,920 --> 00:50:42,680 IT'S ESSENTIAL THAT USE OF ANY 1428 00:50:42,680 --> 00:50:44,760 GIVEN APPROACH IS PREDICATED ON 1429 00:50:44,760 --> 00:50:45,400 THE NEED. 1430 00:50:45,400 --> 00:50:47,600 THAT MEANS IN TERMS OF THE 1431 00:50:47,600 --> 00:50:48,680 SCIENTIFIC APPROPRIATENESS OF 1432 00:50:48,680 --> 00:50:49,920 THE MODEL AND ITS RELEVANCE TO 1433 00:50:49,920 --> 00:50:51,840 THE RESEARCH INQUIRY TO SUPPORT 1434 00:50:51,840 --> 00:50:53,240 RIGOROUS AND REPRODUCIBLE 1435 00:50:53,240 --> 00:50:54,040 STUDIES. 1436 00:50:54,040 --> 00:50:55,320 BUT IT'S CRITICAL THAT WE 1437 00:50:55,320 --> 00:50:57,480 ACKNOWLEDGE THAT SOME OF THESE 1438 00:50:57,480 --> 00:50:58,320 POTENTIAL -- THE POTENTIAL OF 1439 00:50:58,320 --> 00:51:01,080 SOME OF THESE METHODS HAVE BEEN 1440 00:51:01,080 --> 00:51:02,160 OVERSOLD, AND THE VALUE MAY BE 1441 00:51:02,160 --> 00:51:03,400 LIMITED IN TERMS OF THE SCOPE 1442 00:51:03,400 --> 00:51:04,840 AND INSIGHT THEY CAN PROVIDE 1443 00:51:04,840 --> 00:51:06,360 INTO THE ACTUAL COMPLEXITY OF 1444 00:51:06,360 --> 00:51:08,200 HUMAN BIOLOGY, BEHAVIOR AND 1445 00:51:08,200 --> 00:51:09,360 DISEASE. 1446 00:51:09,360 --> 00:51:10,360 ADDITIONALLY, MANY OF THE ISSUES 1447 00:51:10,360 --> 00:51:12,080 THAT WE'VE DISCUSSED IN THE PAST 1448 00:51:12,080 --> 00:51:13,400 REGARDING RIGOR AND 1449 00:51:13,400 --> 00:51:15,640 TRANSLATABILITY IN ANIMAL MODELS 1450 00:51:15,640 --> 00:51:17,720 MUST ALSO BE ADDRESSED IN THESE 1451 00:51:17,720 --> 00:51:19,400 NON-ANIMAL MODELS, SUCH AS 1452 00:51:19,400 --> 00:51:20,800 CONSIDERATIONS OF HUMAN 1453 00:51:20,800 --> 00:51:22,920 BIOLOGICAL RELEVANCE, STUDY 1454 00:51:22,920 --> 00:51:25,440 DESIGN, STATISTICAL ANALYSES, 1455 00:51:25,440 --> 00:51:27,040 DATA SHARING, AND REPORTING. 1456 00:51:27,040 --> 00:51:28,200 HOWEVER, THERE ARE ALSO 1457 00:51:28,200 --> 00:51:29,080 ADDITIONAL CONSIDERATIONS THAT 1458 00:51:29,080 --> 00:51:31,880 ARE UNIQUE FOR RIGOR AND 1459 00:51:31,880 --> 00:51:34,280 TRANSLATABILITY, AND ALTERNATE 1460 00:51:34,280 --> 00:51:36,080 METHODS WITH THE DEVELOPMENT OF 1461 00:51:36,080 --> 00:51:39,560 NEW TECHNOLOGIES CAN OUTPACE 1462 00:51:39,560 --> 00:51:40,200 SCIENTIFIC CONSENSUS ON 1463 00:51:40,200 --> 00:51:40,680 STANDARDS. 1464 00:51:40,680 --> 00:51:42,080 SO BY UNDERSTANDING THE 1465 00:51:42,080 --> 00:51:43,440 LIMITATIONS OF THESE METHODS AND 1466 00:51:43,440 --> 00:51:45,960 IN WHAT TYPE OF RESEARCH STUDIES 1467 00:51:45,960 --> 00:51:47,040 THEY'RE LIKELY TO SURFACE, NIH 1468 00:51:47,040 --> 00:51:48,960 CAN REALLY START TO APPROACH 1469 00:51:48,960 --> 00:51:49,600 ADDRESSING THESE LIMITATIONS 1470 00:51:49,600 --> 00:51:52,560 WHERE POSSIBLE AND FOCUS ON 1471 00:51:52,560 --> 00:51:53,640 STRATEGICALLY INVESTING RESEARCH 1472 00:51:53,640 --> 00:51:55,120 INTO METHODS AND MODELS THAT ARE 1473 00:51:55,120 --> 00:51:56,760 BEST ABLE TO ANSWER THE RESEARCH 1474 00:51:56,760 --> 00:51:59,720 QUESTION AT HAND. 1475 00:51:59,720 --> 00:52:00,960 SO WHAT WE REALLY WANTED TO 1476 00:52:00,960 --> 00:52:02,400 BRING TO YOU ALL TODAY IS WHAT 1477 00:52:02,400 --> 00:52:04,360 IS NEEDED, WHICH IS AN HONEST 1478 00:52:04,360 --> 00:52:05,720 ASSESSMENT OF THE SCIENTIFIC 1479 00:52:05,720 --> 00:52:06,400 OPPORTUNITY. 1480 00:52:06,400 --> 00:52:08,120 BOTH IN TERMS OF WHERE THESE 1481 00:52:08,120 --> 00:52:09,000 TECHNOLOGIES HOLD PROMISE AND 1482 00:52:09,000 --> 00:52:10,680 WHERE THEY ARE LIMITED IN 1483 00:52:10,680 --> 00:52:11,440 APPROACH. 1484 00:52:11,440 --> 00:52:13,520 IT'S OBVIOUSLY ALREADY A TOPIC 1485 00:52:13,520 --> 00:52:14,640 OF INTENSE INTEREST AMONGST THE 1486 00:52:14,640 --> 00:52:15,760 SCIENTIFIC COMMITTEE. 1487 00:52:15,760 --> 00:52:17,160 YOU ALL HEARD ABOUT THIS 1488 00:52:17,160 --> 00:52:18,960 PREVIOUSLY FROM THE ACD'S PRIOR 1489 00:52:18,960 --> 00:52:21,680 WORKING GROUP ON ENHANCING 1490 00:52:21,680 --> 00:52:23,120 RIGOR, TRANS PARINS SEE AND 1491 00:52:23,120 --> 00:52:24,760 TRANSLATABILITY IN ANIMAL 1492 00:52:24,760 --> 00:52:27,240 RESEARCH, WHICH WAS VERY -- A 1493 00:52:27,240 --> 00:52:28,200 BEAUTIFUL SET OF RECOMMENDATIONS 1494 00:52:28,200 --> 00:52:32,040 LED BY LARRY TABAK AND BARBARA 1495 00:52:32,040 --> 00:52:32,960 WALD ON THE CALL TODAY. 1496 00:52:32,960 --> 00:52:35,720 WE ALSO HAD A NATIONAL ACADEMY 1497 00:52:35,720 --> 00:52:36,680 STUDY EXAMINING OPPORTUNITIES 1498 00:52:36,680 --> 00:52:37,920 FOR ALTERNATIVE METHODS TO 1499 00:52:37,920 --> 00:52:40,080 COMPLEMENT OR REDUCE RELIANCE ON 1500 00:52:40,080 --> 00:52:41,280 NIH-SUPPORTED RESEARCH OF 1501 00:52:41,280 --> 00:52:45,280 NON-HUMAN PRIMATES, AND ALSO 1502 00:52:45,280 --> 00:52:45,920 COMPLEMENTARY INITIATIVES ACROSS 1503 00:52:45,920 --> 00:52:47,120 THE U.S. GOVERNMENT SUCH AS THE 1504 00:52:47,120 --> 00:52:50,320 FDA, THE EPA, AND VETERANS 1505 00:52:50,320 --> 00:52:52,560 ASSOCIATION -- ADMINISTRATION. 1506 00:52:52,560 --> 00:52:54,000 SO WITH THIS INFORMATION AT HAND 1507 00:52:54,000 --> 00:52:55,400 AND WORKING COLLECTIVELY ACROSS 1508 00:52:55,400 --> 00:52:57,200 THE SCIENTIFIC COMMUNITY, WE CAN 1509 00:52:57,200 --> 00:52:58,640 BEGIN TO STRATEGICALLY 1510 00:52:58,640 --> 00:53:00,800 PRIORITIZE AREAS OF RESEARCH IN 1511 00:53:00,800 --> 00:53:01,720 WHICH ALTERNATIVES HOLD VALUE, 1512 00:53:01,720 --> 00:53:04,840 EITHER TO CATALYZE NEW SCIENCE, 1513 00:53:04,840 --> 00:53:06,680 IMPORTANTLY, AREAS IN WHICH 1514 00:53:06,680 --> 00:53:08,000 INCREASED FOCUS MIGHT ACTUALLY 1515 00:53:08,000 --> 00:53:09,120 CATALYZE THE NEW TECHNOLOGIES 1516 00:53:09,120 --> 00:53:10,120 THEMSELVES. 1517 00:53:10,120 --> 00:53:12,440 SO I OFTEN REFER TO CRISPR AS A 1518 00:53:12,440 --> 00:53:13,280 REALLY BEAUTIFUL EXAMPLE HERE. 1519 00:53:13,280 --> 00:53:15,080 WE HAD GENE EDITING CAPABILITIES 1520 00:53:15,080 --> 00:53:17,600 FOR QUITE SOME TIME IN THE 1521 00:53:17,600 --> 00:53:21,520 RECOMBINANT DNA WORLD WITH 1522 00:53:21,520 --> 00:53:24,000 NUCLEASES AND MEGA NUCLEASES. 1523 00:53:24,000 --> 00:53:26,600 THEY WERE DRAMATICALLY 1524 00:53:26,600 --> 00:53:27,920 REVOLUTIONIZED VIA THE INVENTION 1525 00:53:27,920 --> 00:53:30,720 OF CRISPR, WHICH HAS REALLY 1526 00:53:30,720 --> 00:53:32,120 DEMOCRATIZED THE WAY WE'RE ABLE 1527 00:53:32,120 --> 00:53:33,800 TO DO THE SCIENCE, CLEARLY THE 1528 00:53:33,800 --> 00:53:35,360 INVESTMENT IN TECHNOLOGY CROW 1529 00:53:35,360 --> 00:53:43,360 ATED NEW AVENCREATEDNEW AVENUESC 1530 00:53:43,360 --> 00:53:43,640 COMMUNITY. 1531 00:53:43,640 --> 00:53:44,280 SO THAT BRINGS US TO THE NEW 1532 00:53:44,280 --> 00:53:45,760 CHARGE TO THE ACD WHICH IS 1533 00:53:45,760 --> 00:53:46,680 REALLY THINKING ABOUT 1534 00:53:46,680 --> 00:53:48,000 ARTICULATING THE HIGH PRIORITY 1535 00:53:48,000 --> 00:53:49,960 AREAS FOR NIH INVESTMENT IN THE 1536 00:53:49,960 --> 00:53:52,200 USE AND DEVELOPMENT OF NOVEL 1537 00:53:52,200 --> 00:53:54,840 ALTERNATIVE METHODS TO, ONE, 1538 00:53:54,840 --> 00:53:56,160 ADVANCE PROGRESS INTO 1539 00:53:56,160 --> 00:53:57,280 UNDERSTANDING SPECIFIC 1540 00:53:57,280 --> 00:54:02,440 BIOLOGICAL PROCESSES OR STATES, 1541 00:54:02,440 --> 00:54:04,000 AND TWO, AUGMENT THE TOOLS AND 1542 00:54:04,000 --> 00:54:05,280 CAPABILITIES FOR BIOMEDICAL 1543 00:54:05,280 --> 00:54:07,760 RESEARCH TO COMPLEMENT AND/OR 1544 00:54:07,760 --> 00:54:09,480 POTENTIALLY REPLACE TRADITIONAL 1545 00:54:09,480 --> 00:54:10,360 MODELS. 1546 00:54:10,360 --> 00:54:11,440 WE'RE STILL FLESHING OUT THE 1547 00:54:11,440 --> 00:54:12,760 FINAL CHARGE AND WELCOME THE 1548 00:54:12,760 --> 00:54:16,880 ACD'S INPUT HERE TODAY. 1549 00:54:16,880 --> 00:54:18,440 AS MENTIONED BY TARA EARLIER, 1550 00:54:18,440 --> 00:54:20,680 THIS WILL BE CO-CHAIRED BY 1551 00:54:20,680 --> 00:54:23,720 HOWARD CHANG AND MYSELF. 1552 00:54:23,720 --> 00:54:25,920 WE ARE LOOKING FOR VOLUNTEERS 1553 00:54:25,920 --> 00:54:27,680 FROM THE ACD AND WORKING ACROSS 1554 00:54:27,680 --> 00:54:29,560 THE COMMUNITY TO GET EXPERTISE 1555 00:54:29,560 --> 00:54:30,920 IN THOSE WORKING WITH 1556 00:54:30,920 --> 00:54:34,360 ALTERNATIVE MODELS, THOSE WHO 1557 00:54:34,360 --> 00:54:36,040 HAVE EXPERTISE IN CREATING 1558 00:54:36,040 --> 00:54:37,760 BENCHMARK FOR ALTERNATIVE MODELS 1559 00:54:37,760 --> 00:54:39,240 AND THINKING ABOUT 1560 00:54:39,240 --> 00:54:39,920 TRANSLATABILITY ACROSS THESE 1561 00:54:39,920 --> 00:54:41,440 VARIOUS SECTORS. 1562 00:54:41,440 --> 00:54:44,560 ALSO INTERESTED IN EXPERTISE 1563 00:54:44,560 --> 00:54:45,880 FROM INDUSTRY AS WELL AS THOSE 1564 00:54:45,880 --> 00:54:48,640 WORKING TO TRANSLATE INTO ACTUAL 1565 00:54:48,640 --> 00:54:51,720 PRODUCTS FOR PATIENTS. 1566 00:54:51,720 --> 00:54:53,080 SO THE PROCESS IS ONGOING. 1567 00:54:53,080 --> 00:54:55,720 STAY TUNED, WE WILL GIVE YOU A 1568 00:54:55,720 --> 00:54:57,520 FULL UPDATE IN DECEMBER, AND OUR 1569 00:54:57,520 --> 00:55:00,520 PLANS FOR MOVING FORWARD, AGAIN, 1570 00:55:00,520 --> 00:55:02,960 ARE THE ROSTER BEING POPULATED 1571 00:55:02,960 --> 00:55:04,320 AND REPORT OUT IN DECEMBER. 1572 00:55:04,320 --> 00:55:05,680 WE WILL DISCUSS THE WORK PLAN 1573 00:55:05,680 --> 00:55:09,080 WITH THE ACD, AND THEN PLAN FOR 1574 00:55:09,080 --> 00:55:11,400 A VERY BUSY SPRING, WORKING ON 1575 00:55:11,400 --> 00:55:12,880 LOOKING THROUGH THE LANDSCAPE 1576 00:55:12,880 --> 00:55:15,440 ASSESSMENT IN THE AREAS OF 1577 00:55:15,440 --> 00:55:16,040 OPPORTUNITY. 1578 00:55:16,040 --> 00:55:17,280 THE GOAL IS TO PRESENT 1579 00:55:17,280 --> 00:55:18,840 PRELIMINARY FINDINGS TO THE ACD 1580 00:55:18,840 --> 00:55:22,240 IN JUNE OF NEXT YEAR, AND THEN 1581 00:55:22,240 --> 00:55:24,200 REALLY ENGAGE IN SOME FOCUSED 1582 00:55:24,200 --> 00:55:25,200 STAKEHOLDER ENGAGEMENT TO 1583 00:55:25,200 --> 00:55:26,800 UNDERSTAND AND GET FEEDBACK ON 1584 00:55:26,800 --> 00:55:28,080 ANY PRELIMINARY RECOMMENDATIONS 1585 00:55:28,080 --> 00:55:29,520 TO ISSUE A FINAL REPORT IN 1586 00:55:29,520 --> 00:55:31,520 DECEMBER. 1587 00:55:31,520 --> 00:55:33,320 SO I TRIED TO CATCH US UP ON 1588 00:55:33,320 --> 00:55:35,560 TIME, TARA, BUT I HOPEFULLY LEFT 1589 00:55:35,560 --> 00:55:39,200 A FEW MINUTES FOR QUESTIONS. 1590 00:55:39,200 --> 00:55:40,560 >>THAT WAS GREAT. 1591 00:55:40,560 --> 00:55:40,960 THANKS, LYRIC. 1592 00:55:40,960 --> 00:55:41,880 WE HAVE FIVE MINUTES. 1593 00:55:41,880 --> 00:55:44,960 I ALREADY SEE A HAND UP, SO 1594 00:55:44,960 --> 00:55:46,360 ATUL, YOU WANT TO START OFF THE 1595 00:55:46,360 --> 00:55:46,720 Q & A? 1596 00:55:46,720 --> 00:55:48,920 >>I THINK THIS WAS GREAT. 1597 00:55:48,920 --> 00:55:51,240 I THINK THE CULTURE OF 1598 00:55:51,240 --> 00:55:52,080 COMPLEMENTARY AND ALTERNATIVE 1599 00:55:52,080 --> 00:55:53,680 MAYBE CAN CONFUSE PEOPLE BECAUSE 1600 00:55:53,680 --> 00:55:54,760 THERE ARE OTHER THINGS NAMED 1601 00:55:54,760 --> 00:55:56,160 WITH SOME OF THOSE PHRASES, SOME 1602 00:55:56,160 --> 00:55:59,000 OF THE OTHER -- CULTURE. 1603 00:55:59,000 --> 00:56:00,880 JUST TO ADD INTO INSILICO, SINCE 1604 00:56:00,880 --> 00:56:02,520 NIH IS GOING TO BE REQUIRING SO 1605 00:56:02,520 --> 00:56:03,680 MANY PEOPLE TO SHARE DATA 1606 00:56:03,680 --> 00:56:05,080 STARTING IN LATE JANUARY, HOW 1607 00:56:05,080 --> 00:56:09,440 ABOUT SOME DATA-DRIVEN ONES AS 1608 00:56:09,440 --> 00:56:10,360 WELL, COMPUTER DATA-DRIVEN. 1609 00:56:10,360 --> 00:56:12,560 I KNOW INSILL COAL IS A -- 1610 00:56:12,560 --> 00:56:16,400 CATEGORY BUT MAYBE REAL WORLD, 1611 00:56:16,400 --> 00:56:17,680 EVIDENCE WORLD FOR CLINICAL. 1612 00:56:17,680 --> 00:56:20,720 A LOT OF THESE SEEM TO BE 1613 00:56:20,720 --> 00:56:21,800 MOLECULAR, YOU MIGHT WANT TO 1614 00:56:21,800 --> 00:56:23,880 THROW THEM A BONE OR TWO HERE 1615 00:56:23,880 --> 00:56:24,320 TOO. 1616 00:56:24,320 --> 00:56:27,200 THANKS. 1617 00:56:27,200 --> 00:56:28,200 >>THANKS. 1618 00:56:28,200 --> 00:56:30,400 I SEE BARBARA'S HAND UP AND THEN 1619 00:56:30,400 --> 00:56:31,080 DINAH. 1620 00:56:31,080 --> 00:56:32,080 BARBARA? 1621 00:56:32,080 --> 00:56:34,320 >>HI. 1622 00:56:34,320 --> 00:56:35,320 TWO THINGS. 1623 00:56:35,320 --> 00:56:39,960 FIRST OF ALL, I'M ENORMOUSLY 1624 00:56:39,960 --> 00:56:41,400 IMPRESSED A BIT AND A PART OF 1625 00:56:41,400 --> 00:56:43,280 THIS DID COME OUT OF THE ANIMAL 1626 00:56:43,280 --> 00:56:44,600 RIGOR, AND I'M HAPPY TO SEE THAT 1627 00:56:44,600 --> 00:56:46,480 GOING FORWARD. 1628 00:56:46,480 --> 00:56:49,240 BUT WITH RESPEKD RESPECT TO THEH 1629 00:56:49,240 --> 00:56:50,680 OF THINGS BEING CONSIDERED HERE, 1630 00:56:50,680 --> 00:56:52,320 THE BREADTH IS ENORMOUS, AND I 1631 00:56:52,320 --> 00:56:55,400 WONDER WHETHER THERE'S ANY 1632 00:56:55,400 --> 00:56:56,840 DEBATE AS YOU'RE SETTING THIS UP 1633 00:56:56,840 --> 00:56:59,600 ABOUT WHETHER IT'S GOING TO STAY 1634 00:56:59,600 --> 00:57:01,360 AS BROAD AS PRESENTED, WHICH 1635 00:57:01,360 --> 00:57:05,680 SEEMED ALMOST TO BE SORT OF 1636 00:57:05,680 --> 00:57:06,240 EVERYTHING EXCEPT CLINICAL 1637 00:57:06,240 --> 00:57:06,480 TRIALS. 1638 00:57:06,480 --> 00:57:09,280 IT SEEMED TO BE VERY, VERY 1639 00:57:09,280 --> 00:57:09,720 LARGE. 1640 00:57:09,720 --> 00:57:10,720 AND I'M WONDERING IF THAT'S 1641 00:57:10,720 --> 00:57:16,160 GOING TO GET IN THE WAY OF 1642 00:57:16,160 --> 00:57:17,040 ACHIEVING SPECIFIC -- 1643 00:57:17,040 --> 00:57:17,880 IDENTIFYING AND ACHIEVING 1644 00:57:17,880 --> 00:57:18,640 SPECIFIC GOALS. 1645 00:57:18,640 --> 00:57:19,760 MY SECOND QUESTION IS A MUCH 1646 00:57:19,760 --> 00:57:20,680 QUICKER ONE. 1647 00:57:20,680 --> 00:57:23,600 IN THE REPORT OUT TO NIH AND 1648 00:57:23,600 --> 00:57:26,000 ABOUT HOW NIH DEPLOYS ITS 1649 00:57:26,000 --> 00:57:29,920 RESOURCES, DOES THAT INCLUDE 1650 00:57:29,920 --> 00:57:34,000 ARPA-H? 1651 00:57:34,000 --> 00:57:36,040 >>LARRY, DID YOU WANT TO -- 1652 00:57:36,040 --> 00:57:38,000 >>I'LL TACKLE THE SECOND 1653 00:57:38,000 --> 00:57:38,760 QUESTION AND DEFER QUESTIONS 1654 00:57:38,760 --> 00:57:41,480 ABOUT ARPA-H TO TE TARA, BUT IN 1655 00:57:41,480 --> 00:57:43,080 TERMS OF THE BREADTH AND SCOPE, 1656 00:57:43,080 --> 00:57:45,800 YOU HI HIT THE NAIL ON THE HEADT 1657 00:57:45,800 --> 00:57:46,680 SOME LEVEL. 1658 00:57:46,680 --> 00:57:48,320 WE HAD DONE SOME PRELIMINARY 1659 00:57:48,320 --> 00:57:49,080 INTERNAL ANALYSES ABOUT THE 1660 00:57:49,080 --> 00:57:50,360 SCOPE OF OUR INVESTMENT AND YOU 1661 00:57:50,360 --> 00:57:51,560 SAW THOSE BROAD BUCKETS OF 1662 00:57:51,560 --> 00:57:53,360 CATEGORIES WHICH WE'RE ONLY 1663 00:57:53,360 --> 00:57:54,680 MISSING CLINICAL TRIALS AND 1664 00:57:54,680 --> 00:57:55,320 INVERTEBRATES, RIGHT? 1665 00:57:55,320 --> 00:57:59,000 SO HOW CAN WE MAKE A REALLY 1666 00:57:59,000 --> 00:58:00,760 CLEAR SCOPE, EITHER CAPITALIZING 1667 00:58:00,760 --> 00:58:01,600 ON EMERGING TECHNOLOGY OR 1668 00:58:01,600 --> 00:58:02,920 SOMETHING THAT REALLY CAPTURES 1669 00:58:02,920 --> 00:58:04,360 THE PROMISE AND THE ADVANCE THAT 1670 00:58:04,360 --> 00:58:05,840 WE ARE NOT BOILING THE OCEAN, 1671 00:58:05,840 --> 00:58:09,040 BUT REALLY HAVING A STRATEGIC 1672 00:58:09,040 --> 00:58:10,440 ANALYSIS THAT INFORMS FUTURE 1673 00:58:10,440 --> 00:58:10,880 RESEARCH DIRECTION. 1674 00:58:10,880 --> 00:58:12,360 SO I THINK THIS IS SOMETHING WE 1675 00:58:12,360 --> 00:58:13,560 WILL TAKE BACK TO OUR TEAM TO 1676 00:58:13,560 --> 00:58:15,640 SEE IF WE CAN HONE THIS CHARGE 1677 00:58:15,640 --> 00:58:17,680 AND MAKE IT REALLY CONCRETE WHEN 1678 00:58:17,680 --> 00:58:19,000 WE MEET IN DECEMBER. 1679 00:58:19,000 --> 00:58:21,280 >>IT WOULD BE A GIFT TO THE 1680 00:58:21,280 --> 00:58:25,160 COMMITTEE IF IT'S HONED A LITTLE 1681 00:58:25,160 --> 00:58:28,400 BIT, LEST THEY SPEND THEIR FIRST 1682 00:58:28,400 --> 00:58:29,480 SIX MONTHS DOING SAME. 1683 00:58:29,480 --> 00:58:31,000 >>AND WITH RESPECT TO YOUR 1684 00:58:31,000 --> 00:58:38,440 SECOND QUESTION, BARBARA, WITH 1685 00:58:38,440 --> 00:58:40,960 ARPA-H, AS RENE, THE DIRECTOR OF 1686 00:58:40,960 --> 00:58:44,120 ARPA-H LIKES TO SAY, STARTING 1687 00:58:44,120 --> 00:58:45,880 EVERY CONVERSATION IS, SHE'S ON 1688 00:58:45,880 --> 00:58:48,000 WEEK FOUR, SO SHE NEEDS A 1689 00:58:48,000 --> 00:58:48,480 MINUTE. 1690 00:58:48,480 --> 00:58:49,960 SO SHE'S STILL FORMING SORT OF 1691 00:58:49,960 --> 00:58:54,080 WHAT THE SCOPE OF ARPA-H IS 1692 00:58:54,080 --> 00:58:56,120 GOING TO BE, AND SO WHILE ARPA-H 1693 00:58:56,120 --> 00:58:58,040 IS A PART OF NIH, WE'RE GOING TO 1694 00:58:58,040 --> 00:58:59,280 BE FIGURING SOME OF THIS STUFF 1695 00:58:59,280 --> 00:59:01,880 OUT IN REALTIME. 1696 00:59:01,880 --> 00:59:02,600 >>FAIR ENOUGH. 1697 00:59:02,600 --> 00:59:04,720 I MEAN, IT DOES SEEM LIKE 1698 00:59:04,720 --> 00:59:06,720 THERE'S ROOM FOR SOME ACTUALLY 1699 00:59:06,720 --> 00:59:07,720 REALLY CONSTRUCTIVE, I DON'T 1700 00:59:07,720 --> 00:59:11,080 KNOW WHETHER IT'S OVERLAP OR 1701 00:59:11,080 --> 00:59:12,160 INTERDIGITATION OR WHATEVER, BUT 1702 00:59:12,160 --> 00:59:14,240 SOME OF THESE AREAS LOOK LIKE AT 1703 00:59:14,240 --> 00:59:16,920 LEAST SOME CONCEPTS OF WHAT 1704 00:59:16,920 --> 00:59:21,760 ARPA-H MIGHT INCLUDE IN THE 1705 00:59:21,760 --> 00:59:23,720 PORTFOLIOS, THEY SEEM TO RELATE. 1706 00:59:23,720 --> 00:59:25,800 >>DINA? 1707 00:59:25,800 --> 00:59:31,160 >>YOU MENTIONED IN VITRO AND 1708 00:59:31,160 --> 00:59:32,400 INSILICA IN ANIMAL MODELS, BUT 1709 00:59:32,400 --> 00:59:36,040 IF YOU LOOK AT WHERE -- LIKE WE 1710 00:59:36,040 --> 00:59:37,040 HAVE SO MANY ADVANCES IN THE 1711 00:59:37,040 --> 00:59:38,560 PAST AND IF YOU LOOK AT THE 1712 00:59:38,560 --> 00:59:42,040 SITUATION NOW, MANY OF THE 1713 00:59:42,040 --> 00:59:44,640 DISEASES ARE LEFT WHERE WE HAVE 1714 00:59:44,640 --> 00:59:46,640 HUGE CHALLENGES, LIKE IN 1715 00:59:46,640 --> 00:59:48,040 NEUROSCIENCE, FOR EXAMPLE, OR 1716 00:59:48,040 --> 00:59:51,480 IMMUNOLOGY AS WELL, WHERE NOT 1717 00:59:51,480 --> 00:59:52,680 JUST THE ANIMAL MODELS DON'T 1718 00:59:52,680 --> 00:59:54,440 WORK WELL, BUT ALSO EVEN THE 1719 00:59:54,440 --> 00:59:56,680 SINGLE CELL MODEL, EVEN IF YOU 1720 00:59:56,680 --> 00:59:58,920 BRING IT FROM HUMAN, IT DOESN'T 1721 00:59:58,920 --> 01:00:01,520 WORK AS WELL BECAUSE LIKE 1722 01:00:01,520 --> 01:00:02,840 IMMUNOLOGY, FOR EXAMPLE, IS A 1723 01:00:02,840 --> 01:00:06,560 HUGE SYSTEM AND HUGE NETWORK 1724 01:00:06,560 --> 01:00:10,480 THTHAT INTERACT TOGETHER, SO I 1725 01:00:10,480 --> 01:00:11,560 WONDER IF YOU HAVE MORE ACTUALLY 1726 01:00:11,560 --> 01:00:12,880 GETTING CLOSER TO THE HUMAN 1727 01:00:12,880 --> 01:00:17,320 MAYBE LIKE WITH DATA-DRIVEN 1728 01:00:17,320 --> 01:00:19,280 APPROACHES, BEING ABLE TO 1729 01:00:19,280 --> 01:00:20,640 ADDRESS LIMITATION OF WHERE WE 1730 01:00:20,640 --> 01:00:23,200 ARE HAVING CHALLENGES NOW WITH 1731 01:00:23,200 --> 01:00:26,280 IMMUNOLOGY OR WITH NEUROSCIENCE. 1732 01:00:26,280 --> 01:00:27,680 >>THANK YOU FOR THAT QUESTION. 1733 01:00:27,680 --> 01:00:29,720 AND IT'S WORTH EXPLORING THAT 1734 01:00:29,720 --> 01:00:30,520 MORE IN THE CHARGE. 1735 01:00:30,520 --> 01:00:33,560 SOME OF THE ASPECTS WE'RE 1736 01:00:33,560 --> 01:00:35,200 TALKING ABOUT, THE TECHNOLOGIES 1737 01:00:35,200 --> 01:00:36,040 THEMSELVES, THERE'S STRENGTHS 1738 01:00:36,040 --> 01:00:36,960 AND LIMITATIONS BUT YOU COULD 1739 01:00:36,960 --> 01:00:38,160 FLIP THE QUESTION ON ITS HEAD OF 1740 01:00:38,160 --> 01:00:40,720 WHAT WE ARE TRYING TO MODEL AND 1741 01:00:40,720 --> 01:00:43,600 HOW T TO INCENTIVIZE NEWER AFTER 1742 01:00:43,600 --> 01:00:49,000 PROACHS APPROACHES, SO SOMETHINN 1743 01:00:49,000 --> 01:00:53,200 EXPLORE MORE ABOUT THE REVALUE L 1744 01:00:53,200 --> 01:00:54,040 VALUE FOR THE COMMUNITY. 1745 01:00:54,040 --> 01:00:56,280 >>I THINK THE NIH HAS 1746 01:00:56,280 --> 01:00:57,920 INDIRECTLY ENFORCED THIS MODEL 1747 01:00:57,920 --> 01:00:59,200 BECAUSE OF THE FUNDING. 1748 01:00:59,200 --> 01:01:00,080 TRADITIONALLY WE THOUGHT OF 1749 01:01:00,080 --> 01:01:01,840 EXACTLY THIS PIPELINE, AND THERE 1750 01:01:01,840 --> 01:01:05,320 ARE MORE CHALLENGES -- OF COURSE 1751 01:01:05,320 --> 01:01:08,120 YOU WANT TO GET TO HUMANS WHILE 1752 01:01:08,120 --> 01:01:10,000 YOU ARE SAFE DOING IT AND IN A 1753 01:01:10,000 --> 01:01:11,400 SAFE, REASONABLE WAY THAT DOES 1754 01:01:11,400 --> 01:01:12,480 NOT BURDEN PATIENTS AND 1755 01:01:12,480 --> 01:01:13,360 INDIVIDUALS. 1756 01:01:13,360 --> 01:01:16,080 BUT I MEAN, UNLESS WE ADDRESS 1757 01:01:16,080 --> 01:01:18,360 THIS HURDLE, WE ARE GOING TO 1758 01:01:18,360 --> 01:01:19,560 CONTINUE BUILDING IN THIS DOMAIN 1759 01:01:19,560 --> 01:01:21,160 WHERE WE HAVE A LOT OF EXPERTISE 1760 01:01:21,160 --> 01:01:23,600 BUT WE ARE UNABLE TO SOLVE THIS 1761 01:01:23,600 --> 01:01:26,280 BIG JUMP FOR THESE MAJOR FIELD 1762 01:01:26,280 --> 01:01:30,920 THAT WE DON'T HAVE MUCH IN YET. 1763 01:01:30,920 --> 01:01:32,600 >>THANKS. 1764 01:01:32,600 --> 01:01:34,480 LARRY, I SEE WE'RE AT 6:01, SO 1765 01:01:34,480 --> 01:01:36,120 I'LL TURN IT BACK TO YOU AND, 1766 01:01:36,120 --> 01:01:37,840 AGAIN, WE CAN HAVE MUCH FURTHER 1767 01:01:37,840 --> 01:01:39,920 DISCUSSION ON THESE TOPICS AND 1768 01:01:39,920 --> 01:01:40,920 ADDITIONAL INFORMATION WILL BE 1769 01:01:40,920 --> 01:01:45,800 SHARED IN DECEMBER SO LARRY? 1770 01:01:45,800 --> 01:01:47,200 >>FIRST I WANT TO THANK ALL THE 1771 01:01:47,200 --> 01:01:48,520 MEMBERS OF THE COMMITTEE FOR 1772 01:01:48,520 --> 01:01:51,920 TAKING TIME OUT THIS EVENING TO 1773 01:01:51,920 --> 01:01:54,400 JOIN US. 1774 01:01:54,400 --> 01:01:57,720 I HOPE YOUR INTERESTS HAVE BEEN 1775 01:01:57,720 --> 01:01:58,800 PIQUED, AND THAT THE MEETING IN 1776 01:01:58,800 --> 01:02:00,960 DECEMBER IS NOT GOING TO BE 1777 01:02:00,960 --> 01:02:02,480 BORING. 1778 01:02:02,480 --> 01:02:04,600 WE HAVE THREE REALLY IMPORTANT 1779 01:02:04,600 --> 01:02:06,280 AND INTERESTING TOPICS THAT 1780 01:02:06,280 --> 01:02:11,120 WE'RE GOING TO WANT YOU TO 1781 01:02:11,120 --> 01:02:12,080 WRESTLE WITH AND OF COURSE THERE 1782 01:02:12,080 --> 01:02:13,920 ARE OTHER TOPICS AS WELL BUT WE 1783 01:02:13,920 --> 01:02:15,960 WANTED TO INTRODUCE THESE TO YOU 1784 01:02:15,960 --> 01:02:16,840 AND THE COMMUNITY AT LARGE 1785 01:02:16,840 --> 01:02:18,760 BECAUSE THIS IS A PUBLIC 1786 01:02:18,760 --> 01:02:19,560 MEETING, OF COURSE, TO REALLY 1787 01:02:19,560 --> 01:02:20,800 GET PEOPLE TO BEGIN TO THINK 1788 01:02:20,800 --> 01:02:27,440 ABOUT THESE THINGS. 1789 01:02:27,440 --> 01:02:28,800 BECAUSE THEY ARE COMPLICATED BUT 1790 01:02:28,800 --> 01:02:29,920 THEY ARE VERY, VERY IMPORTANT TO 1791 01:02:29,920 --> 01:02:31,720 THE WAY THE AGENCY SUPPORTS 1792 01:02:31,720 --> 01:02:31,960 SCIENCE. 1793 01:02:31,960 --> 01:02:37,680 SO WITH THAT, WE CERTAINLY LOOK 1794 01:02:37,680 --> 01:02:39,280 FORWARD TO SEEING AS MANY OF YOU 1795 01:02:39,280 --> 01:02:40,840 AS POSSIBLE IN PERSON. 1796 01:02:40,840 --> 01:02:42,920 IF NOT, IF THAT'S NOT POSSIBLE, 1797 01:02:42,920 --> 01:02:46,800 CERTAINLY VIA VIDEO, BECAUSE IT 1798 01:02:46,800 --> 01:02:49,000 WILL BE -- BOTH OPTIONS WILL BE 1799 01:02:49,000 --> 01:02:51,760 AVAILABLE, AND UNTIL THEN, IF 1800 01:02:51,760 --> 01:02:55,560 YOU HAVE IDEAS FOR THE WORKING 1801 01:02:55,560 --> 01:02:57,280 GROUPS OR IF YOU HAVE IDEAS FOR 1802 01:02:57,280 --> 01:02:59,520 THE FIRST TOPIC, PLEASE DON'T BE 1803 01:02:59,520 --> 01:02:59,800 BASHFUL. 1804 01:02:59,800 --> 01:03:01,520 I KNOW THIS GROUP IS NOT 1805 01:03:01,520 --> 01:03:03,160 BASHFUL, BUT PLEASE DON'T BE 1806 01:03:03,160 --> 01:03:06,560 BASHFUL AND SEND IN YOUR 1807 01:03:06,560 --> 01:03:10,000 SUGGESTIONS, ET CETERA, TO TARA. 1808 01:03:10,000 --> 01:03:10,880 AND AGAIN, THANK YOU AND WE LOOK 1809 01:03:10,880 --> 01:03:11,000 FORWARD TO SEEING YOU IN 1810 01:03:11,000 --> 01:03:12,080 DECEMBER. 1811 01:03:12,080 --> 01:03:23,640 HAVE A GOOD EVENING, EVERYBODY.